AU2002242001A1 - Cytoplasmic gene inhibition or gene expression in transfected plants by a tobraviral vector - Google Patents

Description

CYTOPLASMIC GENE INHIBITION

OR GENE EXPRESSION IN TRANSFECTED PLANTS

BY A TOBRAVIRAL VECTOR

FIELD OF THE INVENTION The present invention relates generally to the field of molecular biology and genetics.

Specifically, the present invention relates to a method for transiently expressing a foreign gene in the cytoplasm of a plant host using a tobravirus vector.

BACKGROUND OF THE INVENTION

Great interest exists in launching genome projects in human and non-human genome project. The human genome has between 2.8 million and 3.5 million base pairs, about 3 percent of which are made of genes. In June 2000, the Human Genome Project and biotech company Celera Genomics announced that a rough draft of the human genome has been completed (http://www.ncbi.nlm.nih.gov). This information, however, will only represent a reference sequence of the human genome. The remaining task lies in the determination of sequence functions, which are important for the study, diagnosis, and treatment of human diseases.

The Mouse genome is also being sequenced. Genbank provides about 1.2% of the 3- billion-base mouse genome (http ://www.mformatics.i ax.org) and a rough draft of the mouse genome is expected to be available by 2003 and a finished genome by 2005. In addition, the Drosophila Genome Project has recently been completely (http://www.fruitfly.org). Valuable and basic agricultural plants, including corn, soybeans and rice are also targets for genome projects because the information obtained thereby may prove very beneficial for increasing world food production and improving the quality and value of agricultural products. The United States Congress is considering launching a corn genome project. By helping to unravel the genetics hidden in the corn genome, the project could aid in understanding and combating common diseases of grain crops. It could also provide a big boost for efforts to engineer plants to improve grain yields and resist drought, pests, salt, and other extreme environmental conditions. Such advances are critical for a world population expected to double by 2050. Currently, there are four species which provide 60% of all human food: wheat, rice, corn, and potatoes, and the strategies for increasing the productivity of these plants is dependent on rapid discovery of the presence of a trait in these plants, and the function of unknown gene sequences in these plants.

One strategy that has been proposed to assist in such efforts is to create a database of expressed sequence tags (ESTs) that can be used to identify expressed genes. Accumulation and analysis of expressed sequence tags (ESTs) have become an important component of genome research. EST data may be used to identify gene products and thereby accelerate gene cloning. Various sequence databases have been established in an effort to store and relate the tremendous amount of sequence information being generated by the ongoing sequencing efforts. Some have suggested sequencing 500,000 ESTs for corn and 100,000 ESTs each for rice, wheat, oats, barley, and sorghum. Efforts at sequencing the genomes of plant species will undoubtedly rely upon these computer databases to share the sequence data as it is generated. Arabidopsis thaliana may be an attractive target discovery of a trait and for gene function discovery because a very large set of ESTs have already been produced in this organism, and these sequences tag more than 50% of the expected Arabidopsis genes.

Potential use of the sequence information so generated is enormous if gene function can be determined. It may become possible to engineer commercial seeds for agricultural use to convey any number of desirable traits to food and fiber crops and thereby increase agricultural production and the world food supply. Research and development of commercial seeds has so far focused primarily on traditional plant breeding, however there has been increased interest in biotechnology as it relates to plant characteristics. Knowledge of the genomes involved and the function of genes contained therein for both monocotyledonous and dicotyledonous plants is essential to realize positive effects from such technology.

The impact of genomic research in seeds is potentially far reaching. For example, gene profiling in cotton can lead to an understanding of the types of genes being expressed primarily in fiber cells. The genes or promoters derived from these genes may be important in genetic engineering of cotton fiber for increased strength or for "built-in" fiber color. In plant breeding, gene profiling coupled to physiological trait analysis can lead to the identification of predictive markers that will be increasingly important in marker assisted breeding programs. Mining the DNA sequence of a particular crop for genes important for yield, quality, health, appearance, color, taste, etc., are applications of obvious importance for crop improvement.

Work has been conducted in the area of developing suitable vectors for expressing foreign DNA and RNA in plant and animal hosts. Ahlquist (U.S. Patent Nos. 4,885,248 and 5,173,410) describes preliminary work done in devising transfer vectors which might be useful in transferring foreign genetic material into a plant host for the purpose of expression therein. Additional aspects of hybrid RNA viruses and RNA transformation vectors are described by Ahlquist et al. in U.S. Patent Nos. 5,466,788, 5,602,242, 5,627,060 and 5,500,360. Donson et al, U.S. Patent Nos. 5,316,931, 5,589,367 and 5,866,785 demonstrate for the first time plant viral vectors suitable for the systemic expression of foreign genetic material in plants. Donson et al. describe plant viral vectors having heterologous subgenomic promoters for the systemic expression of foreign genes. Carrington et al, U.S. Patent 5,491,076, describe particular potyvirus vectors also useful for expressing foreign genes in plants. The expression vectors described by Carrington et al. are characterized by utilizing the unique ability of viral polyprotein proteases to cleave heterologous proteins from viral polyproteins. These include Potyviruses such as Tobacco Etch Virus. Additional suitable vectors are described in U.S. Patent Nos 5,811,653 and 5,977,438. Condreay, et al, (Proc. Natl. Acad. Sci. USA 96:127-132) disclose using baculo viruses to deliver and express gene efficiently in cells types of human, primate and rodent origin. Price et al, (Proc. Natl. Acad. Sci. USA 93:9465-9570 (1996)) disclose infecting insect, plant and mammalian cells with Nodaviruses.

Construction of plant RNA viruses for the introduction and expression of non- viral foreign genes in plants has also been demonstrated by Brisson et al., Methods in Enzymology 118:659 (1986), Guzman et al, Communications in Molecular Biology: Viral Vectors, Cold Spring Harbor Laboratory, pp. 172-189 (1988), Dawson et al., Virology 172:285-292 (1989), Takamatsu et al., EMBO J. 6:307-311 (1987), French et al., Science 231 : 1294-1297 (1986), and Takamatsu et al., FEBS Letters 269:73-76 (1990). However, these viral vectors have not been shown capable of systemic spread in the plant and expression of the non- viral foreign genes in the majority of plant cells in the whole plant. Moreover, many of these viral vectors have not proven stable for the maintenance of non-viral foreign genes. However, the viral vectors described by Donson et al, in U.S. Patent Nos. 5,316,931, 5,589,367, and 5,866,785, Turpen in U.S. Patent No. 5,811,653 and 5,977,438, Carrington, et al. in U.S. Patent No. 5,491,076, have proven capable of infecting plant cells with foreign genetic material and systemically spreading in the plant and expressing the non-viral foreign genes contained therein in plant cells locally or systemically. Morsy et al, (Proc. Natl Acad. Sci. USA, 95:7866-7871 (1998)) develop a helper- dependent adenoviral vectors having up to 37Kb insert capacity and being easily propagated. With the recent advent of technology for cloning, genes can be selectively turned off. One method is to create antisense RNA or DNA molecules that bind specifically with a targeted gene's RNA message, thereby interrupting the precise molecular mechanism that expresses a gene as a protein. The antisense technology which deactivates specific genes provides a different approach from a classical genetics approach. Classical genetics usually studies the random mutations of all genes in an organism and selects the mutations responsible for specific characteristics. Antisense approach starts with a cloned gene of interest and manipulates it to elicit information about its function.

The expression of virus-derived positive sense or antisense RNA in transgenic plants provides an enhanced or reduced expression of an endogenous gene. In most cases, introduction and subsequent expression of a transgene will increase (with a positive sense RNA) or decrease (with an antisense RNA) the steady-state level of a specific gene product (Curr. Opin. Cell Biol. 7: 399-405 (1995)). There is also evidence that inhibition of endogenous genes occurs in transgenic plants containing sense RNA (Van der Krol et al, Plant Cell 2(4):291-299 (1990), Napoli et al, Plant Cell 2:279-289 (1990) and Fray et al, Plant Mol. Biol 22:589-602 (1993)).

Post-rrai scriptional gene silencing (PTGS) in transgenic plants is the manifestation of a mechanism that suppresses RNA accumulation in a sequence-specific manner. There are three models to account for the mechanism of PTGS: direct transcription of an antisense RNA from the transgene, an antisense RNA produced in response to over expression of the transgene, or an antisense RNA produced in response to the production of an aberrant sense RNA product of the transgene (Baulcombe, Plant Mol. Biol. 32:79-88 (1996)). The posttranscriptional gene silencing mechanism is typified by the highly specific degradation of either the transgene mRNA or the target RNA, by RNA having either the same or complementary nucleotide sequences. In cases that the silencing transgene is the same sense as the target endogenous gene or viral genomic RNA, it has been suggested that a plant-encoded RNA-dependent RNA polymerase makes a complementary strand from the transgene mRNA and that the small cRNAs potentiate the degradation of the target RNA. Antisense RNA and the hypothetical cRNAs have been proposed to act by hybridizing with the target RNA to either make the hybrid a substrate for double-stranded (ds) RNases or arrest the translation of the target RNA (Baulcombe, Plant Mol. Biol. 32: 79-88 (1996)). It is also proposed that this downregulation or "co-suppression" by the sense RNA might be due to the production of antisense RNA by readthrough transcription from distal promoters located on the opposite strand of the chromosomal DNA (Grierson et α/., Trends Biotechnol. 9:122-123 (1993)).

Kumagai, et al. (Proc. Natl. Acad. Sci. USA 92:1679 (1995)) report that gene expression in transfected Nicotiana benthamiana was cytoplasmic inliibited by viral delivery of a RNA of a known sequence derived from cDNA encoding tomato phytoene desaturase in a positive sense or an antisense orientation. The plant host, Nicotiana benthamiana, and the donor plant, tomato (Lycopersicon esculentum), belong to the same family. There is also evidence that inhibition of endogenous genes occurs in transgenic plants containing sense RNA (Van der Krol et al, Plant Cell 2(4):291-299 (1990), Napoli et al, Plant Cell 2:279-289 (1990) and Fray et al, Plant Mol Biol. 22:589-602 (1993)).

U.S. Patent No. 5,922,602 (Kumagai, et al) discloses a silencing vector comprising dual subgenomic promoters. Kumagai, et al. teach a genetic vector comprising: (a) a first viral subgenomic promoter operably joined to a first nucleic acid sequence that codes for a plant viral coat protein wherein the transcription of the first nucleic acid sequence is regulated by the first plant viral subgenomic promoter; (b) a second plant viral subgenomic promoter operably joined to a second nucleic acid sequence which codes for an anti-sense RNA or a co-suppressor RNA specific for a gene of interest in a plant wherein transcription of the second nucleic acid sequence is regulated by the second plant viral subgenomic promoter; and (c) an origin of replication that initiates replication of the genetic vector in the cytoplasm of a plant cell.

WO 99/36516 (BIOSOURCE TECHNOLOGIES, INC.) discloses a method of determining the function of nucleic acid sequences, changing the phenotypic or biochemical characteristics, and silencing endogenous genes by transfecting a plant host with a recombinant viral nucleic acid comprising a foreign nucleic acid sequence. The recombinant viral nucleic acid is derived from a monopartite plus sense single-stranded RNA virus.

MacFarlane and Popovich (Virology 267:29-35 (2000)) constructed viral vectors from infectious cDNA clones of each of the three tobraviruses, tobacco rattle virus (TRV), pea early- browning virus (PEBV), and pepper ringspot virus (PepRSV). RNA2 of each of the tliree viruses was modified to carry an additional coat protein subgenomic promoter and was used to express green fluorescent protein (GFP). The TRV-GFP construct was prepared by removal of 3' part of the 2b gene and the entire 2c gene. The PEBV-GFP construct was prepared by removal of 2b and 2c genes. The PepRSV-GFP was prepared by removal of 3' part of the 2b gene and the entire 2c gene, [is this correct?] The modified RNA2 constructs that MacFarlane and Popovich teach do not have the entire 2b gene.

The present invention provides a method for either silencing an endogenous gene of a plant host or expressing a foreign gene in a plant host using a monopartite or a bipartite plant viral vector derived from a tobravirus.

SUMMARY OF THE INVENTION

This invention is directed to a bipartite RNA viral vector comprising: (a) modified tobravirus RNA-1 comprising an inserted foreign RNA sequence that codes for all or part of a protein; the inserted sequence is operably linked to the 3 'end of the stop codon of the RNA sequence that codes for a 16k Da cysteine-rich protein of RNA- 1; and (b) tobravirus RNA-2. The tobravirus RNA-2 may comprise a promoter-gene construct inserted in place of the 2C gene, wherein the promoter-gene construct comprises a second foreign RNA sequence. The invention is also directed to a monopartite RNA viral vector comprising: modified tobravirus RNA-1 comprising an inserted foreign RNA sequence; the inserted sequence is operably linked to the 3'end of the stop codon of the RNA sequence which codes for a 16k Da cysteine-rich protein of RNA- 1. The foreign RNA is either in a positive sense or an anti-sense orientation, and is either a complete open reading frame or a partial open reading frame. The invention is directed to a method of simultaneously silencing one or more endogenous host genes and a method of simultaneously silencing a plant host gene and expressing a foreign gene. Such method comprises infecting a plant host with a bipartite vector comprising tobravirus RNA-1 and RNA-2, wherein the RNA-1 comprises a first foreign RNA sequence that codes for all or part of a first protein, and the RNA-2 comprises a second foreign RNA sequence that codes for all or part of a second protein.

The invention is further directed to a method of compiling a plant functional gene profile, a method of changing the phenotype or biochemistry of a plant host, and a method of determining the presence of a trait in a plant host. Such methods comprise the steps of preparing a library of DNA or RNA sequences from a donor plant, and constructing recombinant viral nucleic acids comprising an unidentified nucleic acid insert obtained from said library, wherein said recombinant viral nucleic acids are obtained from a tobravirus.

BRIEF DESCRIPTION OF THE FIGURES

FIG. 1 depicts the tobacco rattle virus gene silencing vector. (A) TRV RNA-1 (LSB-1) contains a replicase gene which produces two proteins, a 134 kDa putative methyl transferase/nucleotide binding/helicase, and 194 kDa kDa putative RNA-dependent RNA polymerase by read-through translation of the UGA termination codon of the 134 kDa open reading frame. Downsteam is a 29 kDa movement protein (mp, la gene), and a 16 kDa

Cysteine Rich Protein (CRP, lb gene). (B) TRV RNA-2 encodes a 22 kDa coat protein (cp, 2a gene), a 40 kDa 2b gene required for nematode transmissibility and a 33 kDa 2c gene of unknown function. FIG. 2 depicts the expression vector pLSB-1. This plasmid contains the T7 promoter, the TRV RNA-1 134-, 194-, 29-, 16-kDa ORFs, and part of the pUC18 plasmid.

FIG. 3 lists the DNA sequence of the TRV RNA-1 clone pLSB-1 (SEQ ID NO: 1). FIG. 4 depicts the plasmid pK20-2b-P/N-SmaI. This plasmid contains the T7 promoter, the TRV RNA-2 22-, 40-kDa ORFs, the Pea Early Browning Virus (PEBV) subgenomic promoter, followed by the PstI and NotI restriction sites, a Smal site linearizing the plasmid prior to transcription, and part of the pUC18 plasmid. The transcriptional start point (tsp) of the subgenomic RNA from the PEBV coat promoter is indicated with a period (.). (SEQ ID NO: 2). FIG. 5 depicts the plasmid pK20-2b-X N-PmeI. This plasmid contains the T7 promoter, the TRV RNA-2 22-, 40-kDa ORFs, the Pea Early Browning Virus (PEBV) subgenomic promoter, followed by the Xhol and NotI restriction sites, a Pmel site for linearizing the plasmid prior to transcription, and part of the pUC18 plasmid. The transcriptional start point (tsp) of the subgenomic RNA from the PEBV coat promoter is indicated with a period (.). (SEQ ID NO: 3). FIG. 6 depicts the plasmid ρK20-2b-P/N-RZ. This plasmid contains the T7 promoter, the TRV RNA-2 22-, 40-kDa ORFs, the Pea Early Browning Virus (PEBV) subgenomic promoter, followed by the PstI and NotI restriction sites, a ribozyme for self-linearizing the plasmid during the transcription reaction, and part of the pUC18 plasmid. The transcriptional start point (tsp) of the subgenomic RNA from the PEBV coat promoter is indicated with a period (.) (SEQ ID NO: 2).

FIG. 7 depicts the plasmids pK20-2b-PDS(+)-SmaI. This plasmid contains the T7 promoter, the TRV RNA-2 22-, 40-kDa ORFs, the Pea Early Browning Virus (PEBV) subgenomic promoter, followed by the N. benthamiana Phytoene Desaturase ORF in the sense orientation, a Smal site for linearizing the plasmid prior to transcription, and part of the pUC18 plasmid. The transcriptional start point (tsp) of the subgenomic RNA from the PEBV coat promoter is indicated with a period (.). (SEQ ID NOS. 4 and 5).

FIG. 8 depicts the plasmids pK20-2b-PDS(-). This plasmid contains the T7 promoter, the TRV RNA-2 22-, 40-kDa ORFs, the Pea Early Browning Virus (PEBV) subgenomic promoter, followed by the N. benthamiana Phytoene Desaturase ORF in the antisense orientation, a Smal site for linearizing the plasmid prior to transcription, and part of the pUCl 8 plasmid. The transcriptional start point (tsp) of the subgenomic RNA from the PEBV coat promoter is indicated with a period (.). FIG. 9 depicts the plasmid pLSB-1 PL. This plasmid contains the T7 promoter, the TRN RΝA-1 134-, 194-, 29-, 16-kDa ORFs, multiple cloning sites Pad, Sse8387I, NotI, NgoMI and Nhel, and part of the pUC18 plasmid. (SEQ ID NO: 6).

FIG. 10 depicts the plasmid pLSB-1 PDS(+). This plasmid contains the T7 promoter, the TRN RΝA- 1 134-, 194-, 29-, 16-kDa ORFs, the Ν. benthamiana Phytoene Desaturase ORF in the sense orientation, and part of the pUC18 plasmid. (SEQ ID. ΝOS. 7 and 8).

FIG. 11 depicts the putative subgenomic promoters in the tobraviral vector LSB-1 PDS(+).

FIG. 12 depicts the plasmid pBS740. FIG. 13 depicts the plasmid 740 AT #120.

FIG. 14 depicts the nucleotide sequence comparison of A. thaliana 740 AT #120 and A. thaliana est AA042085. (SEQ ID ΝOS: 9 and 10).

FIG. 15 depicts the nucleotide sequence comparison of A. thaliana 740 AT #120 and O. sativa est D17760. (SEQ ID ΝOS: 11 and 12). FIG. 16 depicts the plasmid KS+ Νb ARF #3.

FIG. 17 depicts the nucleotide sequence comparison of A. thaliana 740 AT #120 and Ν. benthamiana Νb ARF #3. (SEQ ID ΝOS: 13 and 14).

FIG. 18 depicts the plasmid pK20-2b-120(+)-RZ. (SEQ ID NO. 2). FIG. 19 depicts the plasmid pK20-2b-EPSP(+). (SEQ ID NOS: 15 and 16). FIG. 20 depicts the plasmid pK20-B12(l).

FIG. 21 shows the sequence of pk20-B12 encoded protein. (SEQ ID NO. 17) FIG. 22 depicts the plasmid pK20-Dl 1(1)

FIG. 23 shows the sequence of pK20-Dl 1 encoded protein. (SEQ ID NO. 18). FIG. 24 depicts the plasmid pK20-F12(l). FIG. 25 shows the sequence of pK20-F12(l) encoded protein. (SEQ ID NO. 19).

FIG. 26 depicts the plasmid pK20-B4(3).

FIG. 27 shows the sequence of pK 20-B4(3) encoded protein. (SEQ ID NO. 20). FIG. 28 depicts the plasmid pK20-F12(4).

FIG. 29 shows the sequence of pK20-F12(4) encoded protein. (SEQ ID NO. 21). FIG. 30 depicts the plasmid pK20-G2(4).

FIG. 31 shows the sequence of pK20-G2(4) encoded protein. (SEQ ID NO. 22).

DETAILED DESCRIPTION OF THE INVENTION The present invention is directed to a monopartite RNA viral vector derived from a tobravirus. The monopartite RNA viral vector comprises modified tobravirus RNA-1 that comprises an inserted foreign RNA sequence coding for all or part of a protein. The foreign RNA sequence can be inserted anyplace in RNA-1 as long as it does not affect the replication or infectivity of the viral vector. For example, the foreign RNA sequence can be inserted upstream (to the 5' end) or down stream (to the 3' end) of the 16k Da cystein-rich protein. Preferably, the inserted sequence is operably linked to the 3' end of the the stop codon of the RNA sequence which codes for a 16k Da cysteine-rich protein of RNA- 1. The foreign RNA is either in a positive sense or an anti-sense orientation, and is either a complete open reading frame or a partial open reading frame. When the foreign RNA encodes for all of a protein, the RNA vector can be either an expression vector that expresses a foreign protein, or a silencing vector that inhibits the expression of an endogenous host gene. When the foreign RNA encodes a part of a protein, the RNA vector is likely to be a silencing vector, but it is also possible to be an expression vector depending on whether the construct contains an ATG codon in the correct reading frame.

The present invention is directed to a bipartite RNA viral vector comprising: (a) modified tobravirus RNA-1 comprising a first inserted foreign RNA sequence that codes for all or part of a protein; the inserted sequence is operably linked to the 3 'end of the stop codon of the RNA sequence which codes for a 16k Da cysteine-rich protein of RNA- 1; and (b) tobravirus RNA-2. The presence of tobravirus RNA-2 improves the infectivity of the RNA viral vector. The presence of tobravirus RNA-2 also improves the efficiency of silencing an endogenous gene or expressing a foreign protein. The tobravirus RNA-2 optionally comprises a promoter- gene construct inserted in place of the 2C gene, wherein the promoter-gene construct comprises a second foreign RNA sequence coding for all or part of a protein. The tobravirus RNA-2 may also comprise a subgenomic promoter operably linked to the 5' end of the second foreign RNA sequence. Each of the first and second foreign RNAs is either in a positive sense or an antisense orientation, and is either a complete open reading frame or a partial open reading frame. Each of the first and second foreign RNAs either expresses a protein or inhibits the expression of an endogenous host gene. The foreign RNAs are obtained from either an eukaryotic or a prokaryotic species.

The present invention is also directed to a bipartite RNA viral vector, comprising: (a) tobravirus RNA-1; and (b) modified tobravirus RNA-2; wherein said modified tobravirus RNA-2 comprises at least one promoter-gene construct comprising a subgenomic promoter and a foreign RNA sequence, wherein said subgenomic promoter is operably linked to the 5' end of said foreign RNA sequence, and said promoter-gene construct is inserted in place of the 2c gene and without removal of the 2b gene of a tobravirus. The modified tobravirus RNA-2 may further comprise a polylinker having restriction enzyme Not I, Pst I, and Xhol sites. The present invention is directed to a method of silencing one or more plant host genes.

The method comprises the steps of infecting a plant host with the monopartite RNA viral vector or the bipartite viral vector of this invention, whereby the foreign RNA sequences cause silencing of one or more endogenous plant host genes. When the bipartite RNA vector comprises first and second foreign RNA sequences, more than one plant host genes are simultaneously silenced. The present invention provides methods that are able to silence multiple genes using two different RNAs and express more than one protein in a transfected plant. The method may further comprise a step of allowing the viral vectors to infect the plant host systemically.

The present invention is directed to a method of simultaneously silencing a plant host genes and expressing a foreign gene. The method comprises infecting a plant host with the bipartite RNA vector that comprises first and second foreign RNA sequences according to this invention, whereby the first foreign RNA sequence causes silencing of an endogenous gene of a plant host, and the second foreign RNA is expressed in the plant host, or vice versa. The method may further comprise a step of allowing the viral vectors to infect the plant host systemically.

The present invention is directed to a method of compiling a plant functional gene profile by directional cloning of a library of DNA or RNA sequences from a donor plant. The method comprises: a) preparing a library of DNA or RNA sequences from a donor plant, and constructing recombinant viral nucleic acids comprising an unidentified nucleic acid insert obtained from said library in either a positive sense or an antisense orientation, wherein said recombinant viral nucleic acids are obtained from a tobravirus; b) infecting a plant host with one or more said recombinant viral nucleic acids; c) transiently expressing said unidentified nucleic acid in the plant host; d) determining one or more phenotypic or biochemical changes in the plant host; e) identifying an associated trait relating to a phenotypic or biochemical change; f) identifying said recombinant viral nucleic acid that results in said one or more changes in the plant host; g) repeating steps b) - f ) until at least one nucleic acid sequence associated with said trait is identified, whereby a functional gene profile of the plant host or of the plant donor is compiled. The DNA or RNA sequences from a donor plant can be cDNAs, genomic DNAs, a pool of RNAs or synthetic nucleic acids.

The present invention is directed to a method of compiling a plant functional gene profile by non-directional cloning of a library of DNA or RNA sequences from a donor plant. The method comprises: a) preparing a library of DNA or RNA sequences from a donor plant, and constructing recombinant viral nucleic acids comprising an unidentified nucleic acid insert obtained from said library, wherein recombinant viral nucleic acids are obtained from a tobravirus; b) infecting a plant host with one or more said recombinant viral nucleic acids; c) transiently expressing said recombinant nucleic acid in the plant host; d) determining one or more changes in a phenotypic or biochemical trait in the plant host; e) identifying said recombinant viral nucleic acid that results in said one or more changes in the plant host; f) determining the sequence of said unidentified nucleic acid insert; and g) repeating steps b)-f) until at least one nucleic acid sequence associated with said trait is identified, whereby a functional gene profile of the plant host or the plant donor is compiled. The invention is directed to a method of changing phenotype or a biochemistry of a plant host using recombinant viral nucleic acids comprising an unidentified nucleic acid insert. The method comprises: (a) preparing a library of DNA and RNA sequences of a plant donor; (b) constructing recombinant viral nucleic acids comprising an unidentified nucleic acid insert obtained from said library, wherein said recombinant viral nucleic acids are obtained from a tobravirus; (c) infecting said plant host with one or more said recombinant viral nucleic acids, (d) expressing transiently said unidentified nucleic acid in said plant host; and (e) changing one or more phenotypic or biochemical characteristics in said plant host.

The invention is directed to a method of changing phenotype or a biochemistry of a plant host using recombinant viral nucleic acids comprising a known nucleic acid insert. The method comprises: (a) infecting a plant host with a monopartite or a bipartite viral vector comprising one or more foreign RNA sequences of this invention; (b) expressing transiently the foreign RNA sequence in said plant host; and (c) changing one or more phenotypic or biochemical characteristics in said plant host.

The present invention comprises a method of determining the presence of a trait in a plant host. The method comprises: (a) preparing a library of DNA and RNA sequences of a plant donor; (b) constructing recombinant viral nucleic acids comprising an unidentified_nucleic acid insert obtained from said library in an antisense or a positive sense orientation, wherein said recombinant viral nucleic acid are obtained from a tobravirus; (c) infecting said plant host with one or more said recombinant viral nucleic acids, and expressing transiently said unidentified nucleic acid in said plant host such that one or more phenotypic or biochemical changes occurs; (d) determining one or more biochemical or phenotypic traits relating to said changes in said plant host; and (e) comparing said one or more biochemical or phenotypic traits to a plant host that is uninfected.

The present method has the advantages that the nucleic acid sequence does not need to be known, identified, isolated, or characterized prior to infecting a plant host with a recombinant viral nucleic acid comprising the nucleic acid sequence. Once changes in the plant host is observed, the nucleic acid sequence can be detennined by further identifying the recombinant viral nucleic acid that results in changes in the host, and analyzing the sequence of the nucleic acid insert in the recombinant viral nucleic acid that results in changes in the host.

The present invention provides a method of infecting a plant host by a recombinant plant viral nucleic acid derived from a tobravirus which contains one or more non-native nucleic acid sequences, or by a recombinant plant virus containing a recombinant plant viral nucleic acid derived from a tobravirus. The non-native nucleic acids are subsequently transcribed or expressed in the infected plant host. The products of the non-native nucleic acid sequences result in changing phenotypic traits in the plant host, affecting biochemical pathways within the plant, or affecting endogenous gene expression within the plant.

In one embodiment, a nucleic acid is introduced into a plant host by way of a recombinant viral nucleic acid. Such recombinant viral nucleic acids are stable for the maintenance and transcription or expression of non-native nucleic acid sequences and are capable of systemically transcribing or expressing such non-native sequences in the plant host. Preferred recombinant plant viral nucleic acids useful in the present invention comprise a native plant viral subgenomic promoter, a plant viral coat protein coding sequence, and at least one non-native nucleic acid sequence.

The viral vectors used in accordance with the present invention may be encapsidated by the coat proteins encoded by the recombinant plant virus. The recombinant plant viral nucleic acid or recombinant plant virus is used to infect a plant host. The recombinant plant viral nucleic acid is capable of replication in the host, localized or systemic spread in the host, and transcription or expression of the non-native nucleic acid in the host to affect a phenotypic or biochemical change in the host.

The first step in producing recombinant plant viral nucleic acids is to modify the nucleotide sequences of the plant viral nucleotide sequence by known conventional techniques such that one or more non-native subgenomic promoters are inserted into the plant viral nucleic acid without destroying the biological function of the plant viral nucleic acid. The subgenomic promoters are capable of transcribing or expressing adjacent nucleic acid sequences in a plant host infected by the recombination plant viral nucleic acid or recombinant plant virus. The native coat protein coding sequence may be deleted in some embodiments, placed under the control of a non-native subgenomic promoter in other embodiments, or retained in a further embodiment. If it is deleted or otherwise inactivated, a non-native coat protein gene is inserted under control of one of the non-native subgenomic promoters, or optionally under control of the native coat protein gene subgenomic promoter. The non-native coat protein is capable of encapsidating the recombinant plant viral nucleic acid to produce a recombinant plant virus. Thus, the recombinant plant viral nucleic acid contains a coat protein coding sequence, which maybe native or a normative coat protein coding sequence, under control of one of the native or non-native subgenomic promoters. The coat protein is involved in the systemic infection of the plant host. The chimeric genes and vectors and recombinant plant viral nucleic acids used in this invention are constructed using techniques well known in the art. Suitable techniques have been described in Sambrook et al. (2nd ed.), Cold Spring Harbor Laboratory, Cold Spring Harbor (1982, 1989); Methods in Enzymol (Vols. 68, 100, 101, 118, and 152-155) (1979, 1983, 1986 and 1987); wsADNA Cloning, D.M. Clover, Ed., IRL Press, Oxford (1985). Medium compositions have been described by Miller, J., Experiments in Molecular Genetics, Cold

Spring Harbor Laboratory, New York (1972), as well as the references previously identified, all of which are incorporated herein by reference. DNA manipulations and enzyme treatments are carried out in accordance with manufacturers' recommended procedures in making such constructs. The present invention is not intended to be limited to any particular viral constructs, but rather to include all operable constructs. Specifically, those skilled in the art may choose to transfer DNA or RNA of any size up to and including an entire genome in a plant into a host organism in order to practice the present invention. Those skilled in the art will understand that the recited embodiments are representative only. All operable constructs useful to produce localized or systemic expression of nucleic acids in a plant are within the scope of the present invention.

Preferred plant viruses useful for this invention are bipartite viruses such as bipartite RNA viruses. However, the invention should not be construed as limited to using these particular viruses, but rather the present invention is contemplated to include all suitable viruses. For general information concerning plant viruses, see Matthews, Plant Virology, 3^rd Ed., Academic Press, San Diego (1991). The most preferred tobraviruses are characterized below. Tobraviruses include tobacco rattle tobraviruses (TRV) , pea early-browning viruses

(PEBV) and pepper ringspot viruses. These viruses have two positive-sense, single-stranded genomic RNAs that are separated encapsidated in rod-shaped particles. RNA1 encodes the viral proteins that are responsible for replication and movement of the virus in plants. RNA1 can cause infection in plants in the complete absence of the second RNA (RNA2). RNA2 varies in size, according to virus isolate, and encodes the virus coat protein and sometimes one or more other, nonstructural proteins. (Harrison, B.D., and Robinson, D.J. Tobraviruses. In "The Plant Viruses" M.H.N. van Regenmortel and H. Fraenkel-Conrat, Eds., Vol. 2, pp. 339-369. Plenum Press, New York. (1986))

Tobraviruses have a number of features that make them attractive as gene expression vectors. The smaller viral RNA, RNA2, is nonessential for systemic infection of plants by the virus, which means that it can be extensively modified without affecting virus viability. The CP gene subgenomic RNA promoters of these viruses are, to an extent, interchangeable, which allows the construction of relatively stable constructs containing additional promoters. This raises the possibility that constructs might be built that can express more than one nonviral protein. Tobraviruses, particularly TRN, have a wide host range, suggesting that they could be used as gene vectors in many plant species. Lastly, in contrast to many other plant viruses, tobraviruses are adapted for efficient movement into the root system. This property makes them particularly useful as delivery vectors for testing a wide variety of proteins that may be active in plant-soil/pathogen interactions. Tobraviruses are able to replicate in Arabidopsis, a model plant that has been completely sequenced and has a wealth of genetic mutants.

TRN is able to infect a wide range of plant hosts, including Arabidopsis thaliana, Nicotiana species, Brassica campestris, Capsicum annuum, Chenopodium amaranticolor, Glycine max, Lycopersicon esculentum, Narcissus pseudonarcissus, Petunia X hybrida, Pisum sativum, Solatium tuber osum, Spinacia oleracea, Viciafaba, (http://www.ncbi.nlm.nih.gOv/ICTNdb/ICTNdB/72010004.htm#SymptHost). TRN RΝA-1 (FIGURE 1A) encodes proteins involved in viral replication (Replicase, 134/194 kDa) and movement (Movement Protein (MP) 29 kDa), as well as Cysteine Rich Protein (CRP, 16 kDa). TRN RNA-2a (FIGURE IB) encodes 22 kDa coat protein that encapsidates RNA-1 and RNA- 2 separately into rod shaped particles. The 2b gene encodes for a 40 kDa protein that is required for nematode transmissibility. The 2c gene encodes a 33 kDa protein whose function is not known (MacFarlane, J. Gen. Virol 80:2799-807 (1999)).

In one embodiment of the invention, the invention provides a monopartite RNA viral vector derived from a tobravirus. The monopartite RNA viral vector comprises tobravirus RNA-1 that comprises an inserted foreign RNA sequence coding for all or part of a protein. The foreign RNA sequence can be inserted any place in RNA-1 as long as the insertion does not affect the replication and infectivity of the viral vector. For example, the foreign RNA sequence can be inserted upstream or downstream of the RNA sequence encoding a 16k Da cysteine-rich protein of RNA- 1. In a preferred embodiment, the inserted foreign RNA sequence is operably linked to the 3 'end of the stop codon of the RNA sequence which codes for a 16k Da cysteine- rich protein of RNA- 1. Currently, there are no published reports of multipartite viruses being modified for use as a monopartite silencing system. A monopartite silencing system would be useful for high throughput genomics screening whereby thousands of hosts are inoculated with a virus containing a library of different genes. Viral induced gene silencing of the gene library would create host gene knockouts. Having one DNA template to use for transcribing infectious RNA instead of two would simplify the process of creating gene knockouts. This could make a genomics screening project using a viral vector derived from a tobravirus more economically feasible. In addition, because the 2a (coat protein) and 2b genes from RNA-2 are required for nematode transmissibility (MacFarlane, 1999), an RNA-1 only system would be safer for outdoor field trials.

In another embodiment of the invention, the invention provides a bipartite RNA viral vector derived from a tobravirus. The bipartite RNA viral vector comprising: (a) modified tobravirus RNA-1 comprising a first inserted foreign RNA sequence that codes for all or part of a protein; the inserted sequence is operably linked to the 3 'end of the stop codon of the RNA sequence which codes for a 16k Da cysteine-rich protein of RNA-1; and (b) tobravirus RNA-2. The presence of tobravirus RNA-2 improves the infectivity of the bipartite RNA vector compared with a monopartite RNA vector. The presence of tobravirus RNA-2 also improves the efficiency of silencing of a plant host gene or a gene of interest, and the efficiency of expressing a foreign protein in a plant host.

In another embodiment of the invention, the invention provides a bipartite RNA viral vector derived from a tobravirus. The bipartite RNA viral vector comprises (a) modified tobravirus RNA-1 comprising a first foreign RNA sequence, operably linked to 3 '-end of the stop codon of the RNA sequence which codes for a 16k Da cysteine-rich protein of RNA- 1; and (b) modified tobravirus RNA-2 comprising a promoter-gene construct, which comprises subgenomic promoter operably linked to the 5' end of a second foreign RNA sequence, wherein said promoter-gene construct is inserted in place of the 2C gene. The present invention provides a monopartite RNA vector or a bipartite vector derived from a tobravirus comprising a foreign RNA sequence that encodes for all or part of a protein involved in the regulation of plant growth, h one embodiment of the invention, the protein involves activating, processing or degrading RNAs. In another embodiment of the invention, the protein involves modifying DNAs. Some of such proteins are characterized below. The small nucleolar ribonucleoprotein particles containing H/AC A-type snoRNAs

(H/ACA snoRNPs) are crucial trans-acting factors intervening in eukaryotic ribosome biogenesis. Most of these particles generate the site-specific pseudouridylation of rRNAs while a subset are required for 18S rRNA synthesis. Nhp2p (22kDa) and Nop 1 Op (10 kDa) are conserved, essential and present in the dense fibrillar component of the nucleolus. Nhp2p and Nop 1 Op are specifically associated with all H/ACA snoRNAs and are essential to the function of H/ACA snoRNPs. Cells lacking Nhp2p or Nop 1 Op are impaired in global rRNA pseudouridylation and are in the Al and A2 cleavage steps of the pre-rRNA required for the synthesis of mature 18S rRNA. (Henras, et αl, EMBO. J. 17:7078-90 (1998)).

Structural modulation of RNA is fundamental to proper execution of a large number of intracellular processes, including mRNA maturation, ribosome assembly and translation and often involves a group of proteins, designated RNA helicases, that can unwind RNA:RNA and/or RNA:DNA duplexes. A large number of RNA helicases have been identified and grouped into three families based on their amino acid sequence, i.e., DEAD, DEATH and DECH box families. DEAD box proteins have been found in all the prokaryotes and eukaryotes examined thus far. They share a central core region with seven conserved motifs that are speaced similarly, while the N- and -C-terminal regions of the core differ in both sequence and length among family members. (Okanami, et αl, Nucl Acid Res. 26:2638-43 (1998)). The eukaryotic translation initiation factor 4A, for example, is a member of the DEA(D/H)-box RNA helicase family. (Caruthers, et αl, Proc. Nαtl Acαd. Sci., USA 97:13080- 5 (2000). Dbp5p/Rat8p is a yeast nuclear pore-associated DEAD-box protein essential for RNA export. (Snay-Hodge, et αl, EMBO. J. 17:2663-76 (1998)). The DEAD box RNA helicase family in Arabidopsis thaliana have been described by Aubourg, et al. (Nucl. Acid Res. 27:628- 36 (1991) and Okanami, et al (Nucl. Acid Res. 26:2638-43 (1998)). Telomerase is a ribonucleoprotein reverse transcriptase. The RNA subunit contains a templating sequence complementary to the G-rich strand of the telomere, whereas the telomerase reverse transcriptase (TERT) harbors the catalytic activity for telomere repeat synthesis. Telomerase is an essential enzyme that maintains telomeres on eukaryotic chromosomes. In mammals, telomerase is required for the lifelong proliferative capacity of normal regenerative and reproductive tissues and for sustained growth in a dedifferentiated state. Fitzgerald, et al. (J. Biol. Chem. 275:15962-8 (2000)) have reported the cloning and characterization of the Arabidopsis telomerase reverse transcriptase (TERT) gene. It is known that Nop 10 interacts with telomerase. Plants synthesize S-methyhnethionine (SMM) from S-adenoslymethionine and methionine in a reaction mediated by S-methyltransferase, and use SMM as a methyl donor for methionine synthesis from homocysteine. These reactions comprise the SMM cycle. (Ranocha, et al. Proc. Natl. Acad. Sci. 21:15962-8 (2000)). S-methylfransferase also methylates DNA; the methylated DNA cannot be transcribed into RNA by silencing. The present invention is directed to a method of simultaneously silencing a plant host gene and expressing a foreign gene, and a method of simultaneously silencing more than one endogenous host gene using a bipartite RNA viral vector derived from a tobravirus. The method comprises infecting a plant host with a bipartite vector comprising modified tobravirus RNA-1 and RNA-2, wherein the RNA-1 comprises a first foreign RNA sequence that codes for all or part of a first protein, and the RNA-2 comprises a second foreign RNA sequence that codes for all or part of a second protein. Being able to simultaneously silence one gene in TRV RNA-1 (or RNA-2) and overexpress or silence another gene in TRV RNA-2 (or RNA-1) provides several benefits. It expands the number of biological products that could be produced in plants. Many biological products are secondary metabolites, which may require several enzymatic steps for the plant to manufacture. A multiple gene expression and silencing viral system would be able to modify pathways to make these important products. Secondary metabolites contribute to tastes, scents and colors in food. They also serve as pharmaceuticals (e.g. morphine, vinblastine, taxol) and as defense compounds for plants. In addition, a multiple gene expression and silencing system could allow us to improve the feasibility of expressing gene products in plants by, for example, shutting down expression of endogenous proteases that destroy the desired product, or by reducing levels of endogenous contaminants that hinder purification of the desired product. This system could also redirect carbon flow to the desired products to increase their yield. Furthermore, a multiple gene expression and silencing system could allow us to suppress plant glycosylation patterns of expressed proteins to reduce the likelihood of an allergic reaction in a patient treated with those compounds.

The present invention is directed to a method of altering an alkaloid content in a plant host comprising the steps of infecting a plant host with a monopartite RNA viral vector that comprises modified tobravirus RNA-1. The modified tobravirus RNA-1 comprises a foreign RNA sequence operably linked to the stop codon of the RNA sequence that codes for a 16k Da cysteine-rich protein of RNA- 1. The foreign RNA sequence is involved in the biosynthesis of secondary metabolites, such as alkaloids. For example, the foreign RNA sequence may encode all or part of the putrescine N-methyltransferase. The present invention is also directed to a method of altering an alkaloid content in a plant host comprising the steps of infecting a plant host with a bipartite RNA viral vector that comprises the above modified tobravirus RNA-1 and tobravirus RNA-2.

The present invention is further directed to a method of altering an alkaloid content in a plant host. The method comprises the steps of infecting a plant host with a bipartite RNA viral vector that comprises: (a) tobravirus RNA-1; (b) modified tobravirus RNA-2 that comprises one or more promoter-gene constructs comprising a subgenomic promoter and a foreign RNA sequence, wherein said subgenomic promoter is operably linked to the 5' end of said foreign RNA sequence, and said promoter-gene construct is inserted in place of the 2C gene of a tobravirus. The foreign RNA sequence is involved in the biosynthesis of secondary metabolites, such as alkaloids. For example, the foreign RNA sequence may encode all or part of the putrescine N-methyltransferase. The invention is exemplified by transfecting N. benthamiana plants with a bipartite RNA viral vector that comprises a foreign RNA sequence. The transfected plants showed an 8-fold decrease in the accumulation of the alkaloid nicotine. The protein encoded by the foreign RNA was shown to have high identities and positives with N tabacum putrescine N-methyltransferase. This is the first time that the alkaloid content in a plant was altered by cytoplasmic inhibition of an endogenous gene using a viral RNA vector. The present invention is also directed to a plant host which has an altered alkaloid content, prepared by the above method.

The recombinant plant viral nucleic acid is prepared by cloning a viral nucleic acid. If the viral nucleic acid is DNA, it can be cloned directly into a suitable vector using conventional techniques. One technique is to attach an origin of replication to the viral DNA which is compatible with the cell to be transfected. If the viral nucleic acid is RNA, a full-length DNA copy of the viral genome is first prepared by well-known procedures. For example, the viral RNA is transcribed into DNA using reverse transcriptase to produce subgenomic DNA pieces, and a double-stranded DNA made using DNA polymerases. The cDNA is then cloned into appropriate vectors and cloned into a cell to be transfected. Alternatively, the cDNA is ligated into the vector and is directly transcribed into infectious RNA in vitro, the infectious RNA is then inoculated onto the plant host. The cDNA pieces are mapped and combined in a proper sequence to produce a full-length DNA copy of the viral RNA genome, if necessary. A DNA sequence for a subgenomic promoter, such as a subgenomic coat protein promoter, may optionally be inserted into the nucleic acid at a non-essential site, according to the particular embodiment of the invention utilized. Non-essential sites are those that do not affect the biological properties of the plant viral nucleic acids. Since the RNA genome is the infective agent, the cDNA is positioned adjacent a suitable promoter so that the RNA is produced in the production cell. The RNA can be capped by the addition of a nucleotide in a 5 '-5' linkage using conventional techniques (Dawson et al, Proc. Natl. Acad. Sci. USA, 83:1832 (1986). One or more nucleotides maybe added between the transcription start site of the promoter and the start of the cDNA of a viral nucleic acid to construct an infectious viral vector. In a preferred embodiment of the present invention, the inserted nucleotide sequence contains a G at the 5'- end. In one embodiment, the inserted nucleotide sequence is GNN, GTN, or their multiples, (GNN)_X or (GTN)_X. The capped RNA can be packaged in vitro with added coat protein from TMV to make assembled virions. These assembled virions can then be used to inoculate plants or plant tissues.

Alternatively, an uncapped RNA maybe employed in the embodiments of the present invention. Contrary to the practiced art in scientific literature and in an issued patent (Ahlquist et al, U.S. Patent No. 5,466,788), uncapped transcripts for virus expression vectors are infective on both plants and in plant cells. Capping is not a prerequisite for establishing an infection of a virus expression vector in plants, although capping increases the efficiency of infection.

One feature of the recombinant plant viral nucleic acids useful in the present invention is that they comprise one or more non-native nucleic acid sequences capable of being transcribed in a plant host. These nucleic acid sequences may be native nucleic acid sequences that occur in a plant host. Preferably, these nucleic acid sequences are non-native nucleic acid sequences that do not normally occur in a plant host. These nucleic acid sequences are derived from a donor plant, which may be the same or different from the plant host. The donor plant and the plant host may be genetically remote or unrelated: they may belong to different genus, family, order, class, subdivision, or division. Donor plants and plant hosts include plants of commercial interest, such as food crops, seed crops, oil crops, ornamental crops and forestry crops. For example, wheat, rice, corn, potatoes, barley, tobaccos, soybean canola, maize, oilseed rape, Arabidopsis, Nicotiana can be selected as a donor plant or a plant host. Plant hosts include those capable of being infected by an infectious RNA or a virus containing a recombinant viral nucleic acid. Preferred plant hosts include Nicotiana, such as, Nicotiana benthamiana, and Nicotiana cleavlandii, and Arabidopsis. Plant are grown from seed in a mixture of "Peat-Lite Mix™ (Speedling, Inc. Sun City, FI) and Nutricote™ controlled release fertilizer 14-14-14 (Chiss-Asahi Fertilizer Co., Tokyo, Japan). Plants are grown in a controlled environment provided 16 hours of light and 8 hours of darkness. Sylvania "Gro-Lux/ Aquarium" wide spectrum 40 watt flourescent grow lights. (Osram Sylvania Products, Inc. Danvers, MA) are used. Temperatures are kept at around 80° F during light hours and 70° F during dark hours. Humidity is between 60 and 85%.

To prepare a DNA insert comprising a nucleic acid sequence of a donor plant, the first step is to construct a library of cDNAs, genomic DNAs, or a pool of RNAs of the plant of interest. Full-length cDNAs can be obtained from public or private repositories, for example, cDNA library of Arabidopsis thaliana can be obtained from the Arabidopsis Biological Resource Center. Alternatively, cDNA library can be prepared from a field sample by methods known to a person of ordinary skill, for example, isolating mRNAs and transcribing mRNAs into cDNAs by reverse transcriptase (see, e.g., Sambrook et al, Molecular Cloning: A

Laboratory Manual (2nd ed.), Vols. 1-3, Cold Spring Harbor Laboratory, (1989), or Current Protocols in Molecular Biology, F. Ausubel et al, ed. Greene Publishing and Wiley- Interscience, New York (1987)). Genomic DNAs represented in BAC (bacterial artificial chromosome), YAC (yeast artificial chromosome), or TAC (transformation-competent artificial chromosome, Liu et al, Proc. Natl. Acad. Sci. USA, 96:6535-6540 (1999)) libraries can be obtained from public or private repositories, for example, the Arabidopsis Biological Resource Center. The BAC/YAC/TAC DNAs or cDNAs can be mechanically size-fractionated or digested by an enzyme to smaller fragments. The fragments are ligated to adapters with cohesive ends, and shotgun-cloned into recombinant viral nucleic acid vectors. Alternatively, the fragments can be blunt-end ligated into recombinant viral nucleic acid vectors.

Recombinant plant viral nucleic acids containing a nucleic acid sequence derived from the cDNA library or genomic DNA library is then constructed using conventional techniques. The recombinant viral nucleic acid vectors produced comprise one or more nucleic acid inserts derived from a donor plant. The nucleic acid sequences of the recombinant viral nucleic acids are transcribed as RNAs in a plant host; the RNA are capable of regulating the expression of one or more phenotypic traits by an antisense or a positive sense mechanism, by inhibition of an endogenous plant host gene or by expression of a protein in a plant host. The nucleic acid sequence may also code for the expression of more than one phenotypic trait. Sequences from wheat, rice, corn, potato, barley, tobacco, soybean, canola, maize, oilseed rape, Arabidopsis, and other crop species may be used to assemble the DNA libraries. This method may thus be used to search for useful dominant gene phenotypes from DNA libraries through the gene expression. For a multipartite viral vector construct, more than one nucleic acid is prepared when creating the recombinant plant viral nucleic acid, hi this case, each nucleic acid would require its own origin of assembly. Each nucleic acid could be prepared to contain a subgenomic promoter and a non-native nucleic acid.

In some embodiments of the instant invention, methods to increase the representation of gene sequences in virus expression libraries may also be achieved by bypassing the genetic bottleneck of propagation in bacterial cells. For example, cell-free methods may be used to assemble sequence libraries or individual arrayed sequences into virus expression vectors and reconstruct an infectious virus, such that the final ligation product can be transcribed and the resulting RNA can be used for plant, plant tissue or plant cell inoculation/infection. A more detailed discussion is presented in a co-pending/co-owned U.S. Application No. 09/359,303, which is incorporated herein by reference. Techniques of Infecting a Plant

The host can be infected with a recombinant viral nucleic acid or a recombinant plant virus by conventional techniques. Suitable techniques include, but are not limited to, leaf abrasion, abrasion in solution, high velocity water spray, and other injury of a host as well as imbibing host seeds with water containing the recombinant viral RNA or recombinant plant virus. More specifically, suitable techniques include:

(a) Hand Inoculations. Hand inoculations are performed using a neutral pH, low molarity phosphate buffer, with the addition of celite or carborundum (usually about 1%). One to four drops of the preparation is put onto the upper surface of a leaf and gently rubbed.

(b) Mechanized Inoculations of Plant Beds. Plant bed inoculations are performed by spraying (gas-propelled) the vector solution into a tractor-driven mower while cutting the leaves. Alternatively, the plant bed is mowed and the vector solution sprayed immediately onto the cut leaves.

(c) Vacuum Infiltration. Inoculations may be accomplished by subjecting a host organism to a substantially vacuum pressure environment in order to facilitate infection.

(d) High Speed Robotics Inoculation. Especially applicable when the organism is a plant, individual organisms may be grown in mass array such as in microtiter plates. Machinery such as robotics may then be used to transfer the nucleic acid of interest.

(e) High Pressure Spray of Single Leaves. Single plant inoculations can also be performed by spraying the leaves with a narrow, directed spray (50 psi, 6-12 inches from the leaf) containing approximately 1% carborundum in the buffered vector solution.

(f) Ballistics (High Pressure Gun) Inoculation. Single plant inoculations can also be performed by particle bombardment. A ballistics particle delivery system (BioRad Laboratories, Hercules, (A) can be used to transfect plants such as N benthamiana as described previously (Nagar et al, Plant Cell, 7:705-719 (1995)).

Determine biochemical or phenotypic changes in a plant host.

After a host is infected with a recombinant viral nucleic acid comprising a nucleic acid insert derived from a cDNA library or a genomic library, one or more biochemical or phenotypic changes in a plant host is determined. The biochemical or phenotypic changes in the infected plant host is correlated to the biochemistry or phenotype of a plant host that is uninfected. Optionally, the biochemical or phenotypic changes in the infected plant host is further correlated to a plant host that is infected with a viral vector that contains a control nucleic acid of a known sequence in an antisense orientation; the control nucleic acid has similar size but is different in sequence from the nucleic acid insert derived from the library. For example, if the nucleic acid insert derived from the library is identified as encoding a GTP binding protein, a nucleic acid derived from a gene encoding green fluorescent protein can be used as a control nucleic acid. Green fluorescent protein is known not be have the same effect as the GTP binding protein when expressed in plants.

Those of skill in the art will readily understand that there are many methods to determine phenotypic or biochemical change in a plant and to determine the function of a nucleic acid, once the nucleic acid is localized or systemic expressed in a plant host. In a preferred embodiment, the phenotypic or biochemical trait may be determined by observing phenotypic changes in a host by methods including visual, morphological, macroscopic or microscopic analysis. For example, growth change such as stunting, hyperbranching, and necrosis; structure change such as vein banding, ring spot, etching; color change such as bleaching, chlorosis, or other color; and other changes such as marginal, mottled, patterening, punctate, and reticulate are easily detected, hi another embodiment, the phenotypic or biochemical trait may be determined by complementation analysis, that is, by observing the endogenous gene or genes whose function is replaced or augmented by introducing the nucleic acid of interest. A discussion of such phenomenon is provided by Napoli et al, The Plant Cell 2:279-289 (1990). In a third embodiment, the phenotypic or biochemical trait may be determined by analyzing the biochemical alterations in the accumulation of substrates or products from enzymatic reactions according to any means known by those skilled in the art. h a fourth embodiment, the phenotypic or biochemical trait may be determined by observing any changes in biochemical pathways which may be modified in a host organism as a result of expression of the nucleic acid, h a fifth embodiment, the phenotypic or biochemical trait may be determined utilizing techniques known by those skilled in the art to observe inhibition of endogenous gene expression in the cytoplasm of cells as a result of expression of the nucleic acid. In a sixth embodiment, the phenotypic or biochemical trait may be determined utilizing techniques known by those skilled in the art to observe changes in the RNA or protein profile as a result of expression of the nucleic acid. In a seventh embodiment, the phenotypic or biochemical trait may be determined by selection of organisms such as plants capable of growing or maintaining viability in the presence of noxious or toxic substances, such as, for example herbicides and pharmaceutical ingredients.

Phenotypic traits in plant cells, which may be observed microscopically, macroscopically or by other methods, include improved tolerance to herbicides, improved tolerance to extremes of heat or cold, drought, salinity or osmotic stress; improved resistance to pests (insects, nematodes or arachnids) or diseases (fungal, bacterial or viral), production of enzymes or secondary metabolites; male or female sterility; dwarfness; early maturity; improved yield, vigor, heterosis, nutritional qualities, flavor or processing properties, and the like. Other examples include the production of important proteins or other products for commercial use, such as lipase, melanin, pigments, alkaloids, antibodies, hormones, pharmaceuticals, antibiotics and the like. Another useful phenotypic trait is the production of degradative or inhibitory enzymes, for example, enzymes preventing or inhibiting the root development in malting barley, or enzymes determining response or non-response to a systemically administered drug in a human. The phenotypic trait may also be a secondary metabolite whose production is desired in a bioreactor.

Biochemical changes can also be determined by analytical methods, for example, in a high-throughput, fully automated fashion using robotics. Suitable biochemical analysis may include MALDI-TOF, LC/MS, GC/MS, two-dimensional IEF/SDS-PAGE, ELISA or other methods of analyses. The clones in the plant viral vector library may then be functionally classified based on metabolic pathway affected or visual/selectable phenotype produced in the plant. This process enables the rapid determination of gene function for unknown nucleic acid sequences of a plant origin. Furthermore, this process can be used to rapidly confirm function of full-length DNA' s of unknown gene function. Functional identification of unknown nucleic acid sequences in a plant library may then rapidly lead to identification of similar unknown sequences in expression libraries for other crop species based on sequence homology.

One useful means to determine the function of nucleic acids transfected into a host is to observe the effects of gene silencing. Traditionally, functional gene knockout has been achieved following inactivation due to insertion of transposable elements or random integration of T-DNA into the chromosome, followed by characterization of conditional, homozygous- recessive mutants obtained upon backcrossing. Some teachings in these regards are provided by WO 97/42210 which is herein incorporated by reference. As an alternative to traditional knockout analysis, an EST/DNA library from an organism, for example Arabidopsis thaliana, may be assembled into a plant viral transcription plasmid. The nucleic acid sequences in the transcription plasmid library may then be introduced into plant cells as part of a functional RNA virus which post-transcriptionally silences the homologous target gene. The EST/DNA sequences may be introduced into a plant viral vector in either the plus or minus sense orientation, and the orientation can be either directed or random based on the cloning strategy. A high-throughput, automated cloning scheme based on robotics may be used to assemble and characterize the library. Gene silencing of plant genes is induced by delivering an RNA capable of base pairing with itself to form double stranded regions. This approach could be used with any plant gene to assist in the identification of the function of a particular gene sequence.

The present invention provides a method to produce transfected plants containing viral- derived RNA in the cytoplasm. Such method is much faster than the time required to obtain genetically engineered antisense transgenic plants. Systemic infection and expression of viral antisense RNA occurs as short as four days post inoculation, whereas it takes several months or longer to create a single transgenic plant. The invention provides a method to identify genes involved in the regulation of plant growth by inliibiting the expression of specific endogenous genes or by overexpression of a protein using viral vectors, which replicate solely in the cytoplasm. This invention provides a method to characterize specific genes and biochemical pathways in donor plants or in plant hosts using an RNA viral vector. Cytoplasmic inhibition of gene expression in transfected plants

Nucleic acid sequences that may result in changing a host phenotype include those involved in cell growth, proliferation, differentiation and development; cell communication; and the apoptotic pathway. Genes regulating growth of cells or organisms include, for example, genes encoding a GTP binding protein, a ribosomal protein LI 9 protein, an SI 8 ribosomal protein, etc. Henry, et al. (Cancer Res., 53:1403-1408 (1993)) report that the erb B-2 (or HER- 2 or ne ) gene was amplified and overexpressed in one-third of cancers of the breast, stomach, and ovary; and the mRNA encoding the ribosomal protein LI 9 was more abundant in breast cancer samples that express high levels oferb -2. Lijsebettens, et al. (EMBOJ., 13:3378-3388 (1994)) report that in Arabidopsis, mutation at PFL caused pointed first leaves, reduced fresh weight and growth retardation. PFL codes for ribosomal protein S 18, which has a high homology with the rat S 18 protein. Genes involved in development of cells or organisms include, for example, homeobox-containing genes and genes encoding G-protein-coupled receptor proteins such as the rhodopsin family. Ηomeobox genes are a family of regulatory genes containing a common 183-nucleotide sequence (homeobox) and coding for specific nuclear proteins (homeoproteins) that act as transcription factors. The homeobox sequence itself encodes a 61-amino-acid domain, the homeodomain, responsible for recognition and binding of sequence-specific DNA motifs. The specificity of this binding allows homeoproteins to activate or repress the expression of batteries of down-stream target genes. Initially identified in genes controlling Drosophila development, the homeobox has subsequently been isolated in evolutionarily distant animal species, plants, and fungi. Several indications suggest the involvement of homeobox genes in the control of cell growth and, when dysregulated, in oncogenesis (Cillo et al, Exp. Cell Res., 248:1-9 (1999). Other nucleic acid sequences that may result in changes of an organism include gene-encoding receptor proteins such as hormone receptors, cAMP receptors, serotonin receptors, and the calcitonin family of receptors; and light-regulated DNA encoding a leucine (Leu) zipper motif (Zheng, et al, Plant Physiol, 116:27-35 (1998)). Deregulation or alteration of the process of cell growth, proliferation, differentiation and development; cell communication; and the apoptotic pathways may result in cancer. Therefore, identifying the nucleic acid sequences involved in those processes and determining their functions are beneficial to the human medicine; it also provides a tool for cancer research.

One problem with gene silencing in a plant host is that many plant genes exist in multigene families. Therefore, effective silencing of a gene function may be especially problematic. According to the present invention, more than one nucleic acid may be inserted into the viral vector to effectively silence a particular gene function or to silence the function of a multigene family. It is presently believed that about 20% of plant genes exist in multigene families.

A detailed discussion of some aspects of cytoplasmic inhibition of gene expression in plants is provided in U.S. Patent No. 5,922,602 and WO95/34668, the disclosures of which are incorporated herein by reference. RNA can reduce the expression of a target gene, or a gene of interest, through inhibitory RNA interactions with the mRNA that occur in the cytoplasm and/or the nucleus of a cell. Isolating a conserved gene from a plant The present invention also provides a method of isolating a conserved gene such as a gene encoding a GTP binding protein, DEAD box RNA helicase, NoplO-like small nuclear ribonucleoprotein, putrescine N-methyltransferase, methionine synthase, and PRP19-like spliceosomal protein, and CRS2 chloroplast gene from rice, barley, corn, soybean, maize, oilseed, and other plant of commercial interest, using another gene having homology with gene being isolated. Libraries containing full-length cDNAs from a donor plant such as rice, barley, corn, soybean and other important crops can be obtained from public and private sources or can be prepared from plant mRNAs. The cDNAs are inserted in viral vectors or in small subcloning vectors such as pBluescript (Strategene), pUC18, M13, or pBR322. Transformed bacteria are then plated and individual clones selected by a standard method. The bacteria transformants or DNAs are rearrayed at high density onto membrane filters or glass slides. Full-length cDNAs encoding the protein of interese can be identified by probing filters or slides with labeled nucleic acid inserts which result in changes in a plant host. Useful labels include radioactive, fluorescent, or chemiluminecent molecules, enzymes, etc.

Alternatively, genomic libraries containing sequences from rice, barley, corn, soybean and other important crops can be obtained from public and private sources, or be prepared from plant genomic DNAs. BAC clones containing entire plant genomes have been constructed and organized in a minimal overlapping order. Individual BACs are sheared to fragments and directly cloned into viral vectors. Clones that completely cover an entire BAC form a BAC viral vector sublibrary. Genomic clones can be identified by probing filters containing BACs with labeled nucleic acid inserts which result in changes in a plant host, or for example, with labeled probes prepared from DNAs encoding GTP binding protein from Arabidopsis. Useful labels include radioactive, fluorescent, or chemiluminecent molecules, enzymes, etc. BACs that hybridize to the probe are selected and their corresponding BAC viral vectors are used to produce infectious RNAs. Plants that are transfected with the BAC sublibrary are screened for change of function, for example, change of growth rate or change of color. Once the change of function is observed, the inserts from these clones or their corresponding plasmid DNAs are characterized by dideoxy sequencing. This provides a rapid method to obtain the genomic sequence for a plant protein, for example, a GTP binding protein. Using this method, once the DNA sequence in one plant such as Arabidopsis thaliana is identified, it can be used to identify conserved sequences of similar function that exist in other plant libraries.

Large amounts of DNA sequence information are being generated in the public domain and may be entered into a relational database. Links may be made between sequences from various species predicted to carry out similar biochemical or regulatory functions. Links may also be generated between predicted enzymatic activities and visually displayed biochemical and regulatory pathways. Likewise, links may be generated between predicted enzymatic or regulatory activity and known small molecule inhibitors, activators, substrates or substrate analogs. Phenotypic data from expression libraries expressed in transfected hosts may be automatically linked within such a relational database. Genes with similar predicted roles of interest in other crop plants may be rapidly discovered. Definitions

In order to provide an even clearer and more consistent understanding of the specification and the claims, including the scope given herein to such terms, the following definitions are provided:

Adjacent: A position in a nucleotide sequence proximate to and 5' or 3' to a defined sequence. Generally, adjacent means within 2 or 3 nucleotides of the site of reference.

Anti-Sense Inhibition: A type of gene regulation based on cytoplasmic, nuclear or organelle inhibition of gene expression due to the presence in a cell of an RNA molecule complementary to at least a portion of the mRNA being translated. It is specifically contemplated that the RNA molecule may be from either an RNA virus or mRNA from the host cells genome or from a DNA virus. The gene regulation may either inhibit the endogenous host gene or the target gene of interest. Cell Culture: A proliferating group of cells which may be in either an undifferentiated or differentiated state, growing contiguously or non-contiguously.

Chimeric Sequence or Gene: A nucleotide sequence derived from at least two heterologous parts. The sequence may comprise DNA or RNA. Coding Sequence: A deoxyribonucleotide or ribonucleotide sequence which, when either transcribed and translated or simply translated, results in the formation of a cellular polypeptide or a ribonucleotide sequence which, when translated, results in the formation of a cellular polypeptide.

Compatible: The capability of operating with other components of a system. A vector or plant or animal viral nucleic acid which is compatible with a host is one which is capable of replicating in that host. A coat protein which is compatible with a viral nucleotide sequence is one capable of encapsidating that viral sequence.

Complementation Analysis: As used herein, this term refers to observing the changes produced in an organism when a nucleic acid sequence is introduced into that organism after a selected gene has been deleted or mutated so that it no longer functions fully in its normal role. A complementary gene to the deleted or mutated gene can restore the genetic phenotype of the selected gene.

Dual Heterologous Subgenomic Promoter Expression System (DHSPES): a plus stranded RNA vector having a dual heterologous subgenomic promoter expression system to increase, decrease, or change the expression of proteins, peptides or RNAs, preferably those described in U.S. Patent Nos. 5,316,931, 5,811,653, 5,589,367, and 5,866,785, the disclosure of which is incorporated herein by reference.

Expressed sequence tags (ESTs): A partial sequence of a clone picked at random from a cDNA library and used in the identification of the gene being expressed in a particular tissue. They may be present in either the 5 ' or the 3 ' orientation. ESTs have been shown useful for identifying particular genes.

Expression: The term as used herein is meant to incorporate one or more of transcription, reverse transcription and translation.

A functional Gene Profile: The collection of genes of an organism which code for a biochemical or phenotypic trait. The functional gene profile of an organism is found by screening nucleic acid sequences from a donor organism by over expression or suppression of a gene in a host organism. A functional gene profile requires a collection or library of nucleic acid sequences from a donor organism. A functional gene profile will depend on the ability of the collection or library of donor nucleic acids to cause over-expression or suppression in the host organism. Therefore, a functional gene profile will depend upon the quantity of donor genes capable of causing over-expression or suppression of host genes or of being expressed in the host organism in the absence of a homologous host gene. Foreign DNA or RNA: Any RNA or DNA sequence that does not normally occur in the cell or organism in which it is placed. Examples include recombinant viral nucleic acids and genes or ESTs contained therein. That is, an RNA or DNA sequence may be foreign with respect to a viral nucleic acid. Such an RNA or DNA sequence would not naturally occur in the viral nucleic acid. Also, an RNA or DNA sequence may be foreign with respect to a host organism. That is, such a RNA or DNA sequence would not naturally occur in the host organism.

Gene: A discrete nucleic acid sequence responsible for producing one or more cellular products and/or performing one or more intercellular or intracellular functions.

Gene silencing: A reduction in gene expression. A viral vector expressing gene sequences from a host may induce gene silencing of homologous gene sequences.

Homology: A degree of nucleic acid similarity in all or some portions of a gene sequence sufficient to result in gene suppression when the nucleic acid sequence is delivered in the antisense orientation.

Host: A cell, tissue or organism capable of replicating a nucleic acid such as a vector or viral nucleic acid and which is capable of being infected by a virus containing the viral vector or viral nucleic acid. This term is intended to include prokaryotic and eukaryotic cells, organs, tissues or organisms, where appropriate. Bacteria, fungi, yeast, and animal (cell, tissues, or organisms), are examples of a host.

Infection: The ability of a virus to transfer its nucleic acid to a host or introduce a viral nucleic acid into a host, wherein the viral nucleic acid is replicated, viral proteins are synthesized, and new viral particles assembled. In this context, the terms "transmissible" and "infective" are used interchangeably herein. The term is also meant to include the ability of a selected nucleic acid sequence to integrate into a genome, chromosome or gene of a target organism. Insert: a stretch of nucleic acids, typically more than 20 base pairs long.

Multigene family: A set of genes descended by duplication and variation from some ancestral gene. Such genes may be clustered together on the same chromosome or dispersed on different chromosomes. Examples of multigene families include those which encode the histones, hemoglobins, immunoglobulins, histocompatibility antigens, actions, tubulins, keratins, collagens, heat shock proteins, salivary glue proteins, chorion proteins, cuticle proteins, yolk proteins, and phaseolins.

Non-Native: Any RNA or DNA sequence that does not normally occur in the cell or organism in which it is placed. Examples include recombinant viral nucleic acids and genes or ESTs contained therein. That is, an RNA or DNA sequence may be non-native with respect to a viral nucleic acid. Such an RNA or DNA sequence would not naturally occur in the viral nucleic acid. Also, an RNA or DNA sequence may be non-native with respect to a host organism. That is, such a RNA or DNA sequence would not naturally occur in the host organism.

Nucleic acid: As used herein the term is meant to include any DNA or RNA sequence from the size of one or more nucleotides up to and including a complete gene sequence. The term is intended to encompass all nucleic acids whether naturally occurring in a particular cell or organism or non-naturally occurring in a particular cell or organism. Nucleic acid of interest: The term is intended to refer to the nucleic acid sequence whose function is to be determined. The sequence will normally be non-native to a viral vector but may be native or non-native to a host organism.

Phenotypic Trait: An observable, measurable or detectable property resulting from the expression or suppression of a gene or genes. Plant Cell: The structural and physiological unit of plants, consisting of a protoplast and the cell wall.

Plant Organ: A distinct and visibly differentiated part of a plant, such as root, stem, leaf or embryo.

Plant Tissue: Any tissue of a plant in plant or in culture. This term is intended to include a whole plant, plant cell, plant organ, protoplast, cell culture, or any group of plant cells organized into a structural and functional unit.

Positive-sense inhibition: A type of gene regulation based on cytoplasmic inhibition of gene expression due to the presence in a cell of an RNA molecule substantially homologous to at least a portion of the mRNA being translated. Promoter: The 5 '-flanking, non-coding sequence substantially adjacent a coding sequence which is involved in the initiation of transcription of the coding sequence.

Protoplast: An isolated plant or bacterial cell without some or all of its cell wall. Recombinant Viral Nucleic Acid: Viral nucleic acid which has been modified to contain non-native nucleic acid sequences. These non-native nucleic acid sequences may be from any organism or purely synthetic, however, they may also include nucleic acid sequences naturally occurring in the organism into which the recombinant viral nucleic acid is to be introduced. Recombinant Virus: A virus containing the recombinant viral nucleic acid.

Subgenomic Promoter: A promoter of a subgenomic mRNA of a viral nucleic acid.

Substantial Sequence Homology: Denotes nucleotide sequences that are substantially functionally equivalent to one another. Nucleotide differences between such sequences having substantial sequence homology are insignificant in affecting function of the gene products or an RNA coded for by such sequence.

Systemic Infection: Denotes infection throughout a substantial part of an organism including mechanisms of spread other than mere direct cell inoculation but rather including transport from one infected cell to additional cells either nearby or distant.

Transient Expression: Expression of a nucleic acid sequence in a host without insertion of the nucleic acid sequence into the host genome, such as by way of a viral vector. Transient expression includes expression in the cytoplasm and episomes.

Transposon: A nucleotide sequence such as a DNA or RNA sequence which is capable of transferring location or moving within a gene, a chromosome or a genome.

EXAMPLES

The following examples further illustrate the present invention. These examples are intended merely to be illustrative of the present invention and are not to be construed as being limiting.

EXAMPLE 1

Development Of A Tobraviral Vector For Cytoplasmic Inhibition Of Gene Expression In Transfected Plants

Nematode-transmissible TRV, PpK20, was isolated by Ploeg, Robinson, and Brown (J. Gen. Virol. 74:1463-6 (1993)). A single-lesion purification of this strain was used to make the NM stock (where RNA-1 is purified from the RNA-2, and is maintained as an RNA-1 only infection). Total RNA was purified from plants transfected with NM stock and mixed with infectious RNA-2 from pK20-2b-PDS(+) construct that was prepared by in vitro transcription using T7 DNA-dependent RNA polymerase. The pooled RNAs were used to mechanically coinoculate N benthamiana. Crude leaf extract containing TRV virions was isolated from systemically infected tissue and used to inoculate N. benthamiana. Two weeks after transfection, virions were purified from systemically infected leaf tissue by PEG precipitation (Gooding GV Jr., Hebert TT. A simple technique for purification of tobacco mosaic virus in large quantities. Phytopathology 57(11):1285 (1967)). The TRV RNA-1 was isolated using the RNeasy Mini Kit (Qiagen®) and cDNA was synthesized using the oligonucleotide 5'- TTAATTAAGCATGCGGATCCCGTACGGGCGTAATAACGCTTACGTAGGCGAGGGGT TTTAC-3' (SEQ ID NO: 23) and the cDNA Synthesis System (Gibco BRL®). A 6791 bp full length fragment (1-6791) from TRV RNA-1 encoding the replicase (134/194 kDa), movement protein (29 kDa) and Cysteine Rich Protein (16 kDa) was amplified from the cDNA by PCR using oligonucleotides 5'- ATGAAGAGCATGCTAATACGACTCAC TATAGATAAAACATTTCAATCCTTTGAACGC-3' (upstream) (SEQ ID NO: 24) and 5'- TTCATCTGGATCCCGGGCGTAATAACGCTTACGTAGGCG-3' (downstream) (SEQ ID NO: 25) and cloned into the Sph VBam HI of pUC18 of (Yanisph-Perron, et al, Gene 33:103- 19 (1985)) creating plasmid LSB-1 (FIGURE 2).

DNA sequencing and computer analysis

The nucleotide sequencing of LSB-1 was carried out by dideoxy termination using double-stranded templates (Sanger, et al. Pro. Natl. Acad. Sci. 74:5463-5467 (1977)).

Nucleotide sequence analysis and amino acid sequence comparisons were performed using DNA Strider and SEQUENCHER® (Genecodes) programs. LSB-1 had 29 point mutations when compared to the published sequence for PpK20 RNA-1 (Visser, et al, Virology 263:155- 65 (1999)). ACCESSION AF166084). All of these point mutations were in the replicase gene, and many coded for amino acid substitutions. The sequence of LSB-1 is shown in Figure 3.

Isolation and Modification of TRV RNA-2 cDNA

TRV RNA-2 encodes a capsid protein and two non-structural proteins, 2b and 2c. RNA-2 is not essential for infection in plants. It has been previously modified for expression of heterologous proteins. In this experiment, construct TRV-GFP, (MacFarlane and Popovich, Virology 267:29-35 (2000)) which has the 2b and 2c genes of TRV RNA-2 replaced with the pea early browning virus (PEBV) coat protein subgenomic promoter, was modified by PCR- directed mutagenesis. Oligonucleotides 5'-GTCCTAATCCCTAGGG ATTTAAGG-3' (upstream, TRV2AVR2 SEQ ID NO: 26) and 5'- CTTTGGAAATTGCAGAAAC-3' (downstream, TRV4307-4289, SEQ ID NO: 27) were used to PCR amplify the region between the^vr II and Pst I sites of plasmid TRV-2b-GFP (MacFarlane and Popovich, 2000), which is identical to TRV-GFP but retains the 2b gene. Oligonucleotides 5'- GTTTCTGCAATTTCCAAAG-3 ' (upstream, TRV4289-4307, SEQUENCE NO. 28) and 5 '- GAATTCGGGGTACCGCGGCCGCGATA TCCTGCAGGGCGTTAACTC-3' (downstream, TRVPST/NOT PL, SEQUENCE ID NO: 29) were used to PCR amplify the region between the Pst I and the 3'-end of the PEBV coat protein subgenomic promoter of construct TRV-2b-GFP. The two resulting PCR fragments were then joined by splice overlap PCR using oligonucleotides TRV2 AVR2 and TRVPST/NOT PL and cloned into TRV-GFP cut with Avr H and Kpn I. The resulting construct, ρK20-2b-P/N-SmaI (FIGURE 4), includes the 2b gene and has unique Pst I, EcoRV, and Not I cloning sites, with a Sma I site at the 3 '-terminus of the TRV RNA-2 cDNA insert. Construct pK20-2b-N/P-SmaL in which the Pst I and Not I sites were reversed, was constructed as described above, except oligonucleotide TRVNOT PST PL (5'- GAA TTCGGTACCCTGCAGGATATCGCGGCCGCGGCGTTAACTCGG-3', SEQUENCE ID NO: 30) was used instead of oligonucleotide TRVPST/NOT PL.

Plasmid pK20-2b-P/N-SmaI was modified by adding a Pme I site immediately upstream of the Sma I site. Oligonucleotides 5'- AAGGAAAAAAGCGGCCGCGGTACCC CG-3' (upstream, TRVNOT4979-4995, SEQUENCE ID NO: 31) and 5'- CGGATCC CCCGGGTTTAAACGGG CGTAATAACGCTTACGTAG-3 ' (downstream, TRV23PME1 SEQUENCE ID NO: 32) were used to PCR amplify the region between the Not I and Sma I sites of pK20-2b-P/N-SmaI. The PCR fragment then was recloned into ρK20-2b-P/N-SmaI cut with Not I and Sma I to form the construct pK20-2b-P/N-PmeI. The Pme I site is an eight base- pair recognition site, thereby reducing the probability of cutting within cloned inserts when compared to Sma I (six base-pair recognition site).

Plasmid pK20-2b-P/N-PmeI was further modified by adding a unique Xho I restriction site. Oligonucleotides 5'-AAACTGCAGCTCGAGCTGATTTAACAAATTTTAAC-3' (upstream, PST/XHO ZEO, SEQUENCE ID NO. 33) and 5'-TTTTCCTTTTGCGGCC GCGCACGTGTCAGT CCTGCTCCTCGG-3' (downstream, ZEO NOT SEQUENCE ID NO: 34) were used to PCR amplify the zeocin antibiotic resistance gene of plasmid pTEFl/Zeo

(Invitrogen^®). The PCR fragment was then cloned into pK20-2b-P/N-PmeI cut with Pst I and Not I to form the construct pK20-2b-X/N-Pme I (FIGURE 5), containing a zeocin-resistant gene as a stuffer fragment flanked by unique Xlio I and Not I sites. In addition, a self-cleaving ribozyme (RZ) site was introduced into pK20-2b-P/N-SmaI at the 3 '-terminus of the TRV RNA-2 cDNA insert. This would preclude the necessity of linearizing the plasmid construct with a restriction enzyme prior to in vitro transcription (see below). Oligonucleotides 5'- AAGGAAAAAAGCGGCCGCGGTACC CCG-3' (upstream, TRVNOT4979-4995, SEQUENCE NO: 35) and 5'- GTTTAAACCCGGGCCCGTTTCG TCCTCACGGACTCATCAGCCCGGAAAACACATCCGGGGACGGGCGTAATA ACGTTACGTAG-3' (downstream, TRN23RZ, SEQUENCE ID NO: 36) were used to PCR amplify the region between the Not I and Sma I sites of pK20-2b-P/N-SmaI. The PCR fragment then was recloned into pK20-2b-P/N-SmaI cut with Not I and Sma I to form the construct pK20- 2b-P/N-RZ (FIGURE 6).

Construction of N. benthamiana phytoene desaturase silencing vector

A modified N benthamiana phytoene desaturase cDNA containing unique Nsi I and Not I sites was PCR amplified from the plasmid ρWPF187, which contains SEQ ID NO: 3 of U.S. Patent No. 5,539,093, Fitzmaurice, et al, 1996) using the following oligonucleotides 5'-

TGGTTCTGCAGT TATGCATGCCCCAAATTGGACTTG-3' (upstream, SEQ ID NO: 37) and 5'-TTTT CCTTTTGCGGCCGCTAAACTACGCTTGCTTCTG-3' (downstream, SEQ ID NO: 38). The full-length phytoene desaturase cDNA was then subcloned into the Pst VNot I sites of pK20-2b-P/N-SmaI in the positive orientation and the Not VPst I sites of pK20-2b-N/P- Smal in the antisense orientation. The resulting constructs, pK20-2b-PDS(+)-SmaI (FIGURE 7) and pK20-2b-PDS(-)-SmaI (FIGURE 8), were linearized with Sma I and transcribed using T7 RNA polymerase (Ambion mMessage mMachine). Transcript RNA2 was mixed with transcripts from a full-length clone of TRN RΝA-1 (pLSB-1).

Partial fragments of the PDS gene were also cloned into pK20-2b-P/N-SmaI. Oligonucleotides 5'-CGATAACCTGCAGGATGCCCCAAATTGGACTTGTTTC-3' (upstream, Sse PDS 1 f, SEQUENCE ID NO: 39) and 5'-TGTGTAATGGCGGCCG CAATATGTGCAACCCAG TCTCG-3' (downstream, Not PDS 500 r, SEQUENCE ID NO: 40) were used to PCR amplify the first 500 nucleotides of the N benthamiana PDS gene and oligonucleotides 5'-CGATAACCTGCAGGACAG AAAACTGAAGAACACATCTG-3' (upstream, Sse PDS 1250 f, SEQUENCE ID NO: 41) and 5'-TGTGTAATGGCGG

CCGCCTAAACTACGCTT GCTTCTGC-3' (downstream, Not PDS 1749 r, SEQUENCE ID NO: 42) were used to PCR amplify the last 500 nucleotides. The PCR fragments were then subcloned into the Pst VNot I sites of pk20-2b-P/N-SmaI in the positive orientation. The resulting constructs, pK20-2b-5'PDS(+) andpK20-2b-3'PDS(+), were linearized, transcribed, and mixed with RNA-1 as described above.

Analysis Of N. benthamiana transfected by TRV-PDS Infectious transcripts of TRN RΝA-1 (pLSB-1) were individually mixed with transcripts from pK20-2b-PDS(+), pK20-2b-PDS(-), pK20-2b-5'PDS(+), and pK20-2b-3'PDS(+). The mixtures, designated TRV-2b-PDS(+), TRV-2b-PDS(-), TRV-2b-5'PDS(+), and TRV-2b- 3'PDS(-), respectively, were used to mechanically inoculate N benthamiana. Extracts from infected plants were ground in 25 mM NaPO₄/l% celite (pH7.2) and passaged onto Chenopodium amaranticolor, a local lesion host of TRN. This local lesion infectivity assay verified that the hybrid viruses spread throughout all the non-inoculated upper leaves. The viral symptoms resulting from the infection consisted of distortion of systemic leaves and plant stunting with mild chlorosis. Approximately 6-7 days after transfection, chlorotic areas began to develop in the upper emerging leaves. After 8-10 days, these chlorotic areas bleached white. There was no significant difference in the development and appearance of symptoms whether the PDS gene was in the positive or negative orientation, or whether the full-length or partial fragments of PDS were used. The systemically infected leaves from plants transfected with TRN-2b-PDS(+) containing the full-length PDS gene was shown to accumulate high levels of phytoene (Table 1).

Analysis of Arabidopsis transfected with TRV-GFP and TRV-PDS

Extracts from N. benthamiana infected with TRN-2b-GFP were ground in 25 mM ΝaPO₄/l% celite and passaged onto Arabidopsis. After 5-7 days, systemic expression of GFP was observed. However, the GFP fluorescence begins to visibly fade after 10-13 days; after 14 days, GFP fluorescence was no longer visibly detected. This observation suggests that GFP expression by TRV was reduced in Arabidopsis after an initial phase of overexpression.

Extracts from N. benthamiana infected with TRN-2b-PDS(+) were ground in 25 mM ΝaPO₄/l% celite and passaged onto Arabidopsis. After 7-11 days, TRV-2b-PDS(+) induced the production of white bleached leaves in the systemic leaves, illustrating silencing of PDS gene expression.

Purification and analysis of carotenoids from transfected plants. The carotenoids were isolated from systemically infected tissue and analyzed by HPLC, GC-MS, and UV spectrum HPLC chromatography. Carotenoids were extracted in methanol and identified by their peak retention time and absorption spectra on a 5-cm Jupiter Silica C-18 analytical column using acetonitrile/methanol/2-propanol (85:10:5) as a developing solvent at a flow rate of 0.5 ml/min. Phytoene from plant extracts had an identical retention time to a phytoene standard. The GC-MS spectrum of the phytoene standard matched that of the Wiley 275.L database. The phytoene peak from N. benthamiana transfected with TRV-2b-PDS(+) had an optical absorbence maxima at 285 nm, with shoulders at 276 and 298 nm. Plants transfected with TRV-2b-PDS(+) showed a sixteen-fold increase in phytoene compared to the levels in noninfected plants. Since the colored carotenoids protect chlorophyll from photooxidation, the viral derived cytoplasmic inhibition of phytoene desaturase caused the systemically infected leaves to turn white. This phenotype was also observed in plants that were treated with the herbicide norflurazon, a phytoene desaturase inhibitor. HPLC analysis of norflurazon treated plants revealed that they also accumulated phytoene. Similar data of cytoplasmic inhibition of phytoene desaturase in N. benthamiana plants transfected with the tobamoviral vector TTOl A PDS+ was presented by Kumagai, et al, Proc. Natl Acad. Sci. USA 92: 1679-1683 (1995).

EXAMPLE 2

Development of an RNA-1 Modified Tobraviral Vector for Cytoplamic Inhibition of Gene Expression in Transfected Plants. The first step to making the monopartite silencing system was to insert a polylinker into pLSB-1. The polylinker was inserted at the 3' end of the CRP by splice overlap PCR (Horton, R.M. Hunt, et al, Gene 77:61-8s (1989)). A 1594 bp fragment from the Afl π site (at 5401 in pLSB-1) to the polylinker region at the 3' end of CRP was amplified using the oligonucleotides 5'-AAGTTCTTGCTTAAGACGTCATCG-3* (upstream) (o33, SEQ ID NO: 43) and 5'- GCCGGCCCTGCAGGTTAATTAATCAAAAAGCAAACAAACGATCAATC-3'

(downstream) (o37, SEQ ID NO: 44). A 359 bp fragment from polylinker region at the 3' end of CRP to downstream of the BamHI site (at 7221 in pLSB-1) was amplified using the oligonucleotides 5'- TTAATTAACCTGCAGGGCCGGCGCGGCCGCTAGCTTTTA TTTTATATTGTTATCTGTTTCTG-3' (upstream) (o38, SEQ ID NO: 45). and 5'- CGGATAACAATTTCACACAGGA-3' (downstream) (30B 7792 R, SEQ ID NO: 46). The PCR products were sliced out of an agarose gel (Current Protocols in Molecular Biology) and cleaned up using a Strataprep spin column (Stratagene), then joined together using the oligonucleotides 5'-AAGTTCTTGCTTAAGACGTCATCG-3' (upstream) (o33, SEQ ID NO: 47) and 5'-CGGATAACAATTTCACACAGGA-3' (downstream) (30B 7792 R, SEQ ID NO: 48). The splice overlap PCR product was subcloned into pLSB-1 at AfllJ/BamHI, creating pLSB-1 PL (FIGURE 9). The polylinker region of pLSB-1 PL was verified by DNA sequencing. When N benthaniana plants were coinoculated with pLSB-1 PL and either TRV- 2b-PDS or TRV-2b-GFP, there was little discernible difference in the symptoms displayed by the plant hosts compared to plants coinoculated with the parental construct pLSB-1 and either TRV-2b-PDS or TRV-2b-GFP.

The next step to making a monopartite silencing vector was to insert a plant gene to silence into pLSB-1 PL at the polylinker region. Phytoene desaturase (PDS) was chosen for its distinctive visual phenotype when expression of this gene is knocked out due to viral induced gene silencing. The N. benthamiana PDS allele 2 cDNA was PCR amplified from the plasmid ρWPF187 containing this PDS gene (U.S. Patent No. 5,539,093, Fitzmaurice et al, 1996) using the following oligonucleotides 5'- TGGTTCTGCAGTTATGCATGCCCCAAA TTGGACTTG- 3' (upstream) (SEQ ID NO: 49) and 5'- TTTTCCTTTTGCGGCCGCTAA

ACTACGCTTGCTTCTG-3' (downstream) (SEQ ID NO: 50). The 5' overhangs of these oligonucleotides contain unique Nsi I and Not I sites, which were incorporated upstream and downstream, respectively, of the PDS gene . The phytoene desaturase cDNA was then subcloned into the Sse 8387 I/Not I sites of pLSB-1 PL to make pLSB-1 PDS (+) (FIGURE 10). Note that Sse 8387 1 (Amersham Pharmacia Biotech Inc., Piscataway, NJ 08855) and Nsi I produce compatible cohesive ends.

EXAMPLE 3 Development of a Monopartite Tobraviral Vector for Cytoplamic Inhibition of Gene Expression in Transfected Plants.

DNA template for RNA transcription was made by digesting the plasmid pLSB-1 PDS (+) with Smal to linearize it at the 3' end of the virus. Infectious RNA transcripts were made using components of the mMessage mMachine large scale in vitro transcription kit (Ambion Inc., Austin Texas 78744) in a total volume of 4.3 μl. RNA-1 template transcriptions were done using 0.4 μl 10X Transcription Buffer, 2.0 μl 2X Ribonucleotide Mix, 0.2 μl 30 mM GTP, 1.3 μl DNA template (at roughly 100 ng/μl concentration), and 0.4 μl T7 RNA polymerase enzyme mix. The mixture was inculated 1 to 2 hours at 37°C, then used to inoculate N. benthamiana plants as follows. The RNA transcripts were mixed with 50 μl FES (7.5 g/L glycine, 10.5 g/L dibasic potassium phosphate, 10 g/L sodium pyrophosphate, 10 g/L bentonite, 10 g/L celite), then pipetted on the top surface of two opposite leaves of the plant. Transcript RNA was manually rubbed into the leaves. Inoculated plants were maintained in an indoor greenhouse. When N. benthamiana plants were inoculated with the RNA-1 pLSB-1 PDS(+) alone, there was bleaching of systemic leaves, starting at 2 - 2.5 weeks post inoculation. Thus pLSB-1 PDS (+) is acting as a monopartite silencing vector. Unlike previous viral vectors that were developed for gene silencing in plants, this construct does not contain an additional subgenomic promoter. The phytoene desaturase inhibitor RNA is expressed on a subgenomic RNA that is operationally linked to the endogenous CRP RNA (FIGURE 11).

EXAMPLE 4

Development of a Multifunctional Heterologous Gene Expression/ Silencing Tobraviral Vector.

Being able to simultanously silence one gene in TRV RNA-1 and overexpress or silence others in TRV RNA-2 would provide several benefits. It would greatly expand the number of biological products that could be produced in plants.

To coinoculate plants with both RNA-1 and RNA-2, transcription reactions were set up as indicated in Example 4, with the following differences. The 4.3 μl RNA-2 transcription reaction was set up without added GTP, using 0.4 μl 10X Transcription Buffer, 2.0 μl 2X Ribonucleotide Mix, 0.2 μl water, 1.3 μl DNA template (at roughly 100 ng/μl concentration), and 0.4 μl T7 RNA polymerase enzyme mix. 4.3 μl RNA-1 transcripts and 4.3 μl RNA-2 transcripts were mixed together, then with 50 μl FES and pipetted to plant leaves as indicated in Example 3.

When N benthaniana plants were coinoculated with pLSB-1 PDS (+) and TRV-2b- GFP, there was a delay of about two days in GFP expression and bleaching of systemic leaves due to PDS silencing compared to coinoculation with pLSB-1 and TRV-2b-GFP. There was simultaneous expression of GFP and silencing of PDS on the same systemic leaves by 8 days post inoculation. This indicated that the two RNAs of TRN could be used in a dual gene expression silencing vector system. When N. benthamiana plants were coinoculated with the RΝA-1 construct pLSB-1 PDS(+), and the RNA-2 construct pK20-2b-PDS(+), there was no delay in PDS silencing. EXAMPLE 5 Arabidopsis thaliana cDNA Library Construction In a Dual Subgenomic Promoter Vector.

Arabidopsis thaliana cDNA libraries obtained from the Arabidopsis Biological Resource Center (ABRC). The four libraries from ABRC were size-fractionated to inserts of 0.5-1 kb (CD4-13), 1-2 kb (CD4-14), 2-3 kb (CD4-15), and 3-6 kb (CD4-16). All libraries are of high quality and have been used by several dozen groups to isolate genes. The pBluescript® phagemids from the Lambda ZAP π vector were subjected to mass excision and the libraries were recovered as plasmids according to standard procedures.

Alternatively, the cDNA inserts in the CD4-13 (Lambda ZAP II vector) were recovered by digestion with NotI. Digestion with NotI in most cases liberated the entire Arabidopsis thaliana cDΝA insert because the original library was assembled with NotI adapters. NotI is an 8-base cutter that infrequently cleaves plant DΝA. In order to insert the NotI fragments into a transcription plasmid, the pBS735 transcription plasmid was digested with PacVXhol and ligated to an adapter DΝA sequence created from the oligonucleotides 5'- TCGAGCGGCCGCAT-3' (SEQ ID NO: 51) and 5'-GCGGCCGC-3'. The resulting plasmid pBS740 (FIGURE 12) contains a unique NotI restriction site for bi-directional insertion of NotI fragments from the CD4-13 library. Recovered colonies were prepared from these for plasmid minipreps with a Qiagen BioRobot 9600^®. The plasmid DΝA preps performed on the BioRobot 9600^® were done in 96-well format and yield transcription quality DΝA. An Arabidopsis cDΝA library was transformed into the plasmid and analyzed by agarose gel electrophoresis to identify clones with inserts. Clones with inserts were transcribed in vitro and inoculated onto N. benthamiana ox Arabidopsis thaliana. Selected leaf disks from transfected plants were then taken for biochemical analysis.

EXAMPLE 6 Identification of Nucleotide Sequences Involved in the Regulation of Plant Growth by Cytoplasmic Inhibition of Gene Expression in an Antisense Orientation Using Viral Derived RNA (GTP Binding Proteins).

h this example, we show: (1) a method for producing antisense RNA using an RNA viral vector, (2) a method to produce viral-derived antisense RNA in the cytoplasm, (3) a method to inhibit the expression of endogenous plant proteins in the cytoplasm by viral antisense RNA, and (4) a method to produce transfected plants containing viral antisense RNA, such method is much faster than the time required to obtain genetically engineered antisense transgenic plants. Systemic infection and expression of viral antisense RNA occurs as short as several days post inoculation, whereas it takes several months or longer to create a single transgenic plant. This example demonstrates that novel positive strand viral vectors, which replicate in the cytoplasm, can be used to identify genes involved in the regulation of plant growth by inhibiting the expression of specific endogenous genes. This example enables one to characterize specific genes and biochemical pathways in transfected plants using an RNA viral vector.

Tobamoviral vectors have been developed for the heterologous expression of uncharacterized nucleotide sequences in transfected plants. A partial Arabidopsis thaliana cDNA library was placed under the transcriptional control of a tobamovirus subgenomic promoter in a RNA viral vector. Colonies from transformed E. coli were automatically picked using a Flexys robot and transferred to a 96 well flat bottom block containing terrific broth (TB) Amp 50 μg/ml. Approximately 2000 plasmid DNAs were isolated from overnight cultures using a BioRobot and infectious RNAs from 430 independent clones were directly applied to plants. One to two weeks after inoculation, transfected Nicotiana benthamiana plants were visually monitored for changes in growth rates, morphology, and color. One set of plants transfected with 740 AT #120 (FIGURE 13) were severely stunted. DNA sequence analysis revealed that this clone contained an Arabidopsis GTP binding protein open reading frame (ORF) in the antisense orientation. This demonstrates that an episomal RNA viral vector can be used to deliberately alter the metabolic pathway and cause plant stunting. In addition, our results suggest that the Arabidopsis antisense transcript can turn off the expression of the N. benthamiana gene.

Construction of an Arabidopsis thaliana cDNA library in an RNA viral vector.

An Arabidopsis thaliana CD4-13 cDNA library was digested with NotI. DΝA fragments between 500 and 1000 bp were isolated by trough elution and subcloned into the NotI site of pBS740. E. coli C600 competent cells were transformed with the pBS740 AT library and colonies containing Arabidopsis cDΝA sequences were selected on LB Amp 50 μg/ml. Recombinant C600 cells were automatically picked using a Flexys robot and then transferred to a 96 well flat bottom block containing terrific broth (TB) Amp 50 μg/ml. Approximately 2000 plasmid DΝAs were isolated from overnight cultures using a BioRobot (Qiagen) and infectious RΝAs from 430 independent clones were directly applied to plants.

Isolation of a gene encoding a GTP binding protein. One to two weeks after inoculation, transfected Nicotiana benthamiana plants were visually monitored for changes in growth rates, morphology, and color. Plants transfected with 740 AT #120 were severely stunted. Plasmid 740 AT #120 contains the TMV-U1 126-, 183-, and 30-kDa ORFs, the TMV-U5 coat protein gene (U5 cp), the T7 promoter, an Arabidopsis thaliana CD4-13 NotI fragment, and part of the pUC19 plasmid. The TMV-U1 subgenomic promoter located within the minus strand of the 30-kDa ORF controls the synthesis of the CD4- 13 antisense subgenomic RΝA.

DΝA sequencing and computer analysis.

A 782 bp NotI fragment of 740 AT #120 containing the ADP-ribosylation factor (ARF) cDΝA was characterized. DΝA sequence of NotI fragment of 740 AT #120 (774 base pairs) is as follows: 5'-

CCGAAACATTCTTCGTAGTGAAGCAAAATGGGGTTGAGTTTCGCCAAGCTGTTTAG CAGGCTTTTTGCCAAGAAGGAGATGCGAATTCTGATGGTTGGTCTTGATGCTGCTG GTAAGACCACAATCTTGTACAAGCTCAAGCTCGGAGAGATTGTCACCACCATCCCT ACTATTGGTTTCAATGTGGAAACTGTGGAATACAAGAACATTAGTTTCACCGTGTG GGATGTCGGGGGTCAGGACAAGATCCGTCCCTTGTGAGACACTACTTCCAGAACAC TCAAGGTCTAATCTTTGTTGTTGATAGCAATGACAGAGACAGAGTTGTTGAGGCTC GAGATGAACTCCACAGGATGCTGAATGAGGACGAGCTGCGTGATGCTGTGTTGCTT GTGTTTGCCAACAAGCAAGATCTTCCAAATGCTATGAACGCTGCTGAAATCACAGA TAAGCTTGGCCTTCACTCCCTCCGTCAGCGTCATTGGTATATCCAGAGCACATGTGC CACTTCAGGTGAAGGGCTTTATGAAGGTCTGGACTGGCTCTCCAACAACATCGCTG GCAAGGCATGATGAGGGAGAAATTGCGTTGCATCGAGATGATTCTGTCTGCTGTGT TGGGATCTCTCTCTGTCTTGATGCAAGAGAGATTATAAATATTATCTGAACCTTTTT GCTTTTTTGGGTATGTGAATGTTTCTTATTGTGCAAGTAGATGGTCTTGTACCTAAA AATTTACTAGAAGAACCCTTTTAAATAGCTTTCGTGTATTGT-3 ' (SEQ ID NO: 52). The nucleotide sequencing of 740 AT #120 was carried out by dideoxy termination using double stranded templates. Nucleotide sequence analysis and amino acid sequence comparisons were performed using DNA Strider, PCGENE and NCBI Blast programs. 740 AT #120 contained an open reading frame (ORF) in the antisense orientation that encodes a protein of 181 amino acids with an apparent molecular weight of 20,579 Daltons. Sequence Comparison

FIGURE 14 shows a nucleotide sequence comparison of A. thaliana 740 AT #120 and A. thaliana est AA042085 (SEQ ID NOs: 9 and 10 respectively). The nucleotide sequence from 740 AT #120 is also compared with a rice (Oryza sativa) ADP ribosylation factor D 17760, SEQ ID NOs: 11 and 12 (FIGURE 15); which shows 82% (456/550) positives and identities.

The nucleotide sequence from 740 AT #120 exhibits a high degree of homology (81- 84% identity and positive) to rice, barley, carrot, corn and A. thaliana DNA encoding ARFs; and also a high degree of homology (71-87% identity and positive) to yeast, plants, insects such as fly, amphibian such as frog, mammalian such as bovine, human, and mouse DNA encoding ARFs (Table 2).

The amino acid sequence derived from 740 AT #120 exhibits an even higher degree of homology (96-98% identity and 97-98% positive) to ARFs from rice, carrot, com and A. thaliana and a high degree of homology (61-98% identity and 78-98% positive; higher than nucleotide sequence homology) to ARFs from yeast, plants, insects such as fly, mammalian such as bovine, human, and mouse (Table 3).

The high homology of DNAs encoding GTP binding proteins from yeast, plants, insects, human, mice, and amphibians indicates that DNAs from one donor organism can be transfected into another host organism and silence the endogenous gene of the host organism.

Table 2. 740 AT #120 Nucleotide Sequence Comparison

Score Expect Identities Positives

barley E10542 540.8 bits (1957) 1.4e-157 461/548 (84%) 461/548 (84%)

A. thaliana M95166 538.5 bits (1949) 7.4e-157 461/550 (83%) 461/550 (83%) rice AF012896 537.7 bits (1946) 1.3e-156 462/553 (83%) 462/553 (83%) carrot D45420 531.4 bits (1923) 9.8e-155 471/579 (81%) 471/579 (81%) corn X80042 512.3 bits (1854) 6.8e-149 450/549 (81%) 450/549 (81%)

C. reinhardtii U27120 480.0 bits (1740) 1.6e-139 436/546 (79%) 436/546 (79%) mouse brain ARF3 D87900 431.1 bits (1560) 1.7e-124 416/546 (76%) 416/546 (76%)

Bovine J03794 426.9 bits (1545) 3.6e-123 409/534 (76%) 409/534 (76%)

Human ARF3 M33384 433.5 bits (1569) 4.9e-123 417/546 (76%) 417/546 (76%)

S. /?omøe ARFl L09551 430.2 bits (1557) l.le-121 409/531 (77%) 409/531 (77%)

Human ARF1 AF05502 428 bits (1549) 5.8e-121 405/524 (77%) 405/524 (77%) frog U31350 414.5 bits (1500) 1.7e-119 412/552 (74%) 412/552 (74%)

Human ARF5 M57567 387.4 bits (1402) 1.0e-107 390/527 (74%) 390/527 (74%)

S. cerevisiae J03276 362.8 bits (1313) 1.6e-99 381/529 (72%) 381/529 (72%)

Human ARF4 M36341 358.4 bits (1297) 4.3e-98 377/524 (71%) 377/524 (71%)

C. elegans M36341 149.8 bits (542) 2.0e-90 154/211 (72%) 154/211 (72%)

N. tabacum NTGBl U46927 285.7 bits (1034) 4.8e-78 234/268 (87%) 234/268 (87%)

Human cosmid AC000357 107.5 bits (389) 9.7e-73 93/112 (83%) 93/112 (83%) fly S62079 211.9 bits (767) 2.8e-72 195/247 (78%) 195/247 (78%)

Table 3. Amino acid sequence comparison of 740 AT #120 with ARFs from other organisms.

Score Expect Identities Positives

A. thaliana ARF1 g543841 365 bits (928) e-101 179/181 (98%) 179/181 (98%) rice gl703380 363 bits (921) e-100 177/181 (97%) 179/181 (98%) corn gl 351974 356 bits (905) 3e-98 174/181 (96%) 179/181 (98%) carrot gl703375 362 bits (919) e-100 177/181 (97%) 178/181 (97%)

C. reinhardtii g\ 703374 354 bits (898) 2e-97 172/180 (95%) 174/180 (96%)

Bovine 327 bits (829) 2e-89 160/177 (90%) 166/177 (93%)

Human ARF1 326 bits (827) 4e-89 160/177 (90%) 166/177 (93%) mouse 326 bits (827) 4e-89 160/177 (90%) 166/177 (93%) fly 325 bits (825) 7e-89 158/177 (89%) 166/177 (93%)

Human ARF3 P16587 321 bits (813) le-87 157/180 (87%) 164/180 (90%)

Human ARF5 gl 14127 305 bits (774) 7e-83 145/178 (81%) 161/178 (89%)

Human ARF4 gl 14123 304 bits (770) 2e-82 145/178 (81%) 160/178 (89%) yeast ARFl gl71072 298 bits (754) 2e-80 139/177 (78%) 161/177 (90%)

A. thaliana ARF3 241 bits (608) 2e-63 109/177 (61%) 140/177 (78%)

The protein encoded by 740 AT #120, 120P, contained three conserved domains: the phosphate binding loop motif, GLDAAGKT SEQUENCE ID NO: 53, (consensus GXXXXGKS/T); the G' motif, DVGGQ, SEQUENCE ID NO: 54 (consensus DXXGQ), a sequence which interacts with the gamma-phosphate of GTP; and the G motif NKQD (consensus NKXD), which is specific for guanidinyl binding. The 120P contains a putative glycine-myristoylation site at position 2, a potential N-glycosylation site (NXS) at position 60, and several putative serine/threonine phosphorylations sites.

Isolation of an Arabidopsis thaliana ARF genomic clone A genomic clone encoding A. thaliana ARF can be isolated by probing filters containing thaliana BAC clones using a ³²P-labeled 740 AT #120 NotI insert. Other members of the A. thaliana ARF multigene family have been identified using programs of the University of Wisconsin Genetic Computer Group. The BAC clone T08I13 located on chromosome TJ has a high degree of homology to 740 AT #120 (78% to 86% identity at the nucleotide level).

Isolation and characterization of a cDΝA encoding Nicotiana benthamiana ARF.

A 488 bp cDΝA from N. benthamiana stem cDΝA library was isolated by polymerase chain reaction (PCR) using the following oligonucleotides: ATARFK15, 5' AAG AAG GAG ATG CGA ATT CTG ATG GT 3' (upstream) (SEQ ID ΝO:55), ATARFN176, 5' ATG TTG TTG GAG AGC CAG TCC AGA CC 3' (downstream) (SEQ ID NO: 56). The vent polymerase in the reaction was inactivated using phenol/chloroform, and the PCR product was directly cloned into the ΕLincU site in Bluescript KS+ (Strategene). The plasmid map of KS+ Nb ARF #3, which contains the N. benthamiaca ARF ORF in pBluescript KS+ is shown in FIGURE 16. The nucleotide sequence of N. benthamiana KS+ Νb ARF#3, which contains partial ADP-ribosylation factor ORF, was determined by dideoxynucleotide sequencing. The nucleotide sequence from KS+ Νb ARF#3 had a strong similarity to other plant ADP-ribosylation factor sequences (82 to 87% identities at the nucleotide level). The nucleotide sequence comparison of N. benthamiana KS+ Νb ARF#3 and thaliana 740 AT #120 shows a high homology between them (FIGURE 17, SEQ ID ΝOs: 13 and 14 respectively). The nucleotide sequence of KS+ ΝbARF #3 exhibits a high degree of homology (77-87% identities and positives) to plant, yeast and mammalian DΝA encoding ARFs (Table 4). Again, the high homology of DNAs encoding GTP binding proteins from yeast, plants, human, bovine and mice indicates that DNAs from one donor organism can be transfected into another host organism and effectively silence the endogenous gene of the host organism.

Table 4. KS+ Nb ARF #3 Nucleotide sequence comparison

Score Expect Identities Positives

A. thaliana M95166 448.2 bits (1622) 1.2e-129 366/418 (87%) 366/418 (87%)

C. roseus AF005238 446.0 bits (1614) 5.3e-129 368/427 (86%) 370/427 (86%)

S. bakko AB003377 444.9 bits (1610) l.le-128 366/421 (86%) 366/421 (86%) rice AF012896 425.8 bits (1541) 5.1e-121 357/418 (85%) 357/418 (85%)

V. unguiculata AF022389 425.8 bits (1541) 5.1e-121 857/418 (85%) 357/418 (85%) barley El 0542 413.4 bits (1496) 1.2e-115 356/427 (83%) 356/427 (83%)

S. tuber osum X74461 405.9 bits (1469) 3.5e-115 353/427 (82%) 353/427 (82%) carrot D45420 408.4.4 bits (1478) 3.3e-114 354/427 (82%) 354/427 (82%) corn X80042 400.1 bits (1448) 2.3e-113 348/421 (82%) 348/421 (82%) rice D17760 403.4 bits (1460) 3.7e-112 352/427 (82%) 352/427 (82%)

C reinhardtii U27120 373.6 bits (1352) 5.0e-103 340/427 (79%) 340/427 (79%)

Human ARF3 M33384 367.5.5 bits (1330) 7.1e-101 334/419 (79%) 334/419 (79%) mouse brain ARF3 D87900 355.3 bits (1286) 1.3e-97 330/421 (78%) 330/421 (78%)

Bovine J03794 342.6 bits (1240) 1.4e-95 324/419 (77%) 324/419 (77%)

A full-length cDNA encoding ARF is isolated by screening the N benthamiana cDNA library by colony hybridization using a ³²P-labeled N benthamiana KS+/Nb ARF #3 probe. Hybridization is carried out at 42°C for 48 hours in 50% formamide, 5X SSC, 0.02 M phosphate buffer, 5X Denhart's solution, and 0.1 mg/ml sheared calf thymus DNA. Filters are washed at 65°C in 0.1X SSC, 0.1% SDS prior to autoradiography.

EXAMPLE 7 Transfecting N. Benthamiana Using pK20-2b-120(+)-RZ

The 740AT #120 A. thaliana ARF cDNA was cloned into the Not I site of plasmid pK20-2b-P/N-RZ in the positive orientation. The resulting construct, ρK20-2b- 120(+)-RZ (FIGURE 18) was transcribed using T7 RNA polymerase (Ambion mMessage mMachine), mixed with TRV RNA-1 (pLSB-1) transcripts, and inoculated onto N. benthamiana.

After 7 days, plants transfected with pK20-2b-120(+)-RZ were severely stunted and induced severe necrosis in the systemic leaves.

EXAMPLE 8 Genomic DΝA Library Construction in a Recombinant Viral Nucleic Acid Vector.

Genomic DNAs represented in BAC (bacterial artificial chromosome) or YAC (yeast artificial chromosome) libraries are obtained from the Arabidopsis Biological Resource Center (ABRC). The BAC/YAC DNAs are mechanically size- fractionated, ligated to adapters with cohesive ends, and shotgun-cloned into recombinant viral nucleic acid vectors. Alternatively, mechanically size-fractionated genomic DNAs are blunt-end ligated into a recombinant viral nucleic acid vector. Recovered colonies are prepared for plasmid minipreps with a Qiagen BioRobot 9600®. The plasmid DNA preps done on the BioRobot 9600® are assembled in 96-well format and yield transcription quality DNA. The recombinant viral nucleic acid Arabidopsis genomic DNA library is analyzed by agarose gel electrophoresis (template quality control step) to identify clones with inserts. Clones with inserts are then transcribed in vitro and inoculated onto N. benthamiana or Arabidopsis thaliana. Selected leaf disks from transfected plants are then be taken for biochemical analysis. Genomic DNA from Arabidopsis typically contains a gene every 2.5 kb (kilobases) on average. Genomic DNA fragments of 0.5 to 2.5 kb obtained by random shearing of DNA were shotgun assembled in a recombinant viral nucleic acid expression/knockout vector library. Given a genome size of Arabidopsis of approximately 120,000 kb, a random recombinant viral nucleic acid genomic DNA library would need to contain minimally 48,000 independent inserts of 2.5 kb in size to achieve IX coverage of the Arabidopsis genome. Alternatively, a random recombinant viral nucleic acid genomic DNA library would need to contain minimally 240,000 independent inserts of 0.5 kb in size to achieve IX coverage of ^'the Arabidopsis genome. Assembling recombinant viral nucleic acid expression/knockout vector libraries from genomic DNA rather than cDNA has the potential to overcome known difficulties encountered when attempting to clone rare, low-abundance mRNA's in a cDNA library. A recombinant viral nucleic acid expression knockout vector library made with genomic DNA would be especially useful as a gene silencing knockout library. In addition, the Dual Heterologous Subgenomic Promoter Expression System (DHSPES) expression/knockout vector library made with genomic DNA would be especially useful for expression of genes lacking introns. Furthermore, other plant species with moderate to small genomes (e.g. rose, approximately 80,000 kb) would be especially useful for recombinant viral nucleic acid expression/knockout vector libraries made with genomic DNA. A recombinant viral nucleic acid expression/knockout vector library can be made from existing BAC/YAC genomic DNA or from newly-prepared genomic DNAs for any plant species.

EXAMPLE 9 Construction of a Nicotiana benthamiana NB08 cDNA library.

Vegetative N. benthamiana plants were harvested 3.3 weeks after sowing and sliced up into three groups of tissue: leaves, stems and roots. Each group of tissue was flash frozen in liquid nitrogen and total RNA was isolated from each group separately using the following hot borate method. Frozen tissue was ground to a fine powder with a pre-chilled mortar and pestle, and then further homogenized in a pre-chilled glass tissue grinder. Immediately thereafter, added 2.5 ml/g tissue hot (~82°C) XT Buffer (0.2 M borate decahydrate, 30 mM EGTA, 1% (w/v) SDS, 1% (w/v) deoxycholate (sodium salt) was added. Adjusted pH to 9.0 with 5 N NaOH, treated with 0.1 % DEPC and autoclaved. Before use, added 10 mM dithiothreitol, 15 Nonidet P-40 (NEMO) and 2% (w/v) polyvinylpyrrolidone, MW 40,000 (PVP-40)) was added to the ground tissue. The tissue was homogenized 1-2 minutes and quickly decanted to a pre-chilled Oak Ridge centrifuge tube containing 105 μl of 20 mg/ml proteinase K in DEPC treated water. The tissue grinder was rinsed with an additional 1 ml hot XT Buffer per g tissue, which was then added to rest of the homogenate. The homogenate was incubated at 42°C at 100 rpm for 1.5 h. 2 M KC1 was added to the homogenate to a final concentration of 160 mM, and the mixture was incubated on ice for 1 h to precipitate out proteins. The homogenate was centrifuged at 12,000 x g for 20 min at 4°C, and the supernatant was filtered through sterile miracloth into a DEPC-treated 250 ml centrifuge tube. 8 M LiCl was added to a final concentration of 2 M LiCl and incubated on ice overnight. Precipitated RNA was collected by centrifugation at 12,000 x g for 20 min at 4°C. The pellet was washed three times in 10-20 ml 4°C 2 M LiCl. Each time the pellet was resuspended with a glass rod and then spun at 12,000 x g for 20 min at 4°C. The RNA pellet was suspended in 2 ml 10 mM Tris-HCl (pH 7.5), and purified from insoluble cellular components by spinning at 12,000 x g for 20 min at 4°C. The RNA containing supernatant was transferred to a 50 ml DEPC-treated Oak Ridge tube and precipitated overnight at -20°C with 2.5 volumes of 100 % ethanol. The RNA was pelleted by centrifugation at 9,800 x g for 30 min at 4°C. The RNA pellet was washed in 1-2 ml cold 70°C ethanol and centrifuged at 9,800 x g for 5 min at 4°C. Residual ethanol was removed from the RNA pellet by drying at 37°C, and the RNA was resuspended in 1-2 mL DEPC treated dd- water and transferred to a 1.5 ml microfuge tube. The Oak Ridge tube was rinsed in 500 μl DEPC-treated dd-water, which was then added to the rest of the RNA. The RNA was quantitated by spectrophotometry and quality was assessed by gel electrophoresis. The RNA was then aliquoted into 2 mg aliquots and precipitatation was initiated with 1/10 volume of 3 M sodium acetate, pH 6.0 and 2.5 volumes of cold 100% ethanol. RNA was stored long-term at -80°C and precipitated when needed. Precipitation was done by centrifuging for 30 min at 16,000 x g, and the RNA pellet washed with cold 70% ethanol, and centrifuged for 5 min at 16,000 x g. After drying the pellet under vacuum at 37°C, the RNA was resuspended in DEPC- treated water. This is the total RNA. Messenger RNA was purified from total RNA using a MACS mRNA isolation kit

(Miltenyi Biotec, Auburn CA), following the manufacturer's instructions. A reverse transcription reaction was used to synthesize cDNA from the mRNA template using the Gibco BRL cDNA synthesis and cloning kits (Gaithersburg, MD). Resulting cDNAs were then digested with Sal I and Not I.

EXAMPLE 10 Utility of TRV in Silencing Endogenous Plant Genes To further assess the ability of TRV to silence endogenous plant genes, a cDNA library (NB08) from N. benthamiana seedlings was subcloned into the Xho I and Not I sites of pK20-2b-X/N-PmeI in the positive orientation. Resulting clones were transcribed and coinoculated with TRV RNA-1 transcripts onto individual N. benthamiana plants. Out of 384 clones inoculated, 125 (33%) produced a phenotype different from the TRN- 2b-GFP control. These phenotypes ranged from stunting, chlorosis, necrosis, leaf distortion, or death of the plant. These 384 clones were sequenced and annotated by BLAST X and BLAST Ν analysis.

Several clones analyzed produced a phenotype that would be predicted if the corresponding endogenous gene was inhibited or silenced. For example, for a TRN RΝA- 2 clone containing sequence homologous to α-tubulin induced severe shoot and root stunting, as expected since α-tubulin is involved in cell division in the meristematic tissue. Inhibition of α-tubulin with herbicides in the dinitroaniline family has been shown to also to result a similar phenotype in plants (^"http ://www.agcom.purdue.edu/AgCom/Pubs/WS/WS-23.html). An RΝA-2 clone containing sequence homologous to uroporphyrinogen decarboxylase, an enzyme involved in porphyrin and chlorophyll metabolism, induced necrosis on infected leaves similar to that seen in a hypersensitive response in plants. It has been previously reported that expression of the antisense RNA for this enzyme resulted in the production of "necrotic leaf lesions" (Mock, et al. JBiol Chem. 12:4231-8 (1999)).Collectively, these results strongly show the utility of TRN in silencing endogenous plant genes using homologous gene sequences. Information gained from studies in N. benthamiana could be extended and applied to identifying novel genes in Arabidopsis.

EXAMPLE 11 GC/MS Analysis of a Sample from Infected Plants A selected set of samples from infected plants was analyzed by gas chromatography/mass spectroscopy (GC/MS). Several clones produced a biochemical profile that would be predicted if the corresponding endogenous gene were inhibited or silenced. For example, for a TRN clone contained a homolog to putrescine Ν- methyltransferase, an enzyme in the nicotine biosynthesis pathway; GC MS analysis showed that there was an 8 -fold decrease in nicotine levels in leaves of plants infected with this clone.

EXAMPLE 12 Purification and Analysis of Metabolites From Transfected Plants

Leaf tissue was harvested in triplicate (30-40 mg) from transfected plants at 13 days post-inoculation, placed in 1.5 ml Eppendorf tubes, and dried in a Speedvac (SC210A, Savant) overnight. Controls used were uninoculated leaf tissue and tissue from TRN-2b-GFP infected plants. The controls for extraction were deuterium(d)-labeled internal standard compounds with 50 μl water. Samples were stored at 4°C until processed. Samples were quickly frozen in liquid nitrogen and crushed with a motorized plastic pestle in Eppendorf tubes. HPLC-grade methanol (300 μl) containing internal standards (10 ng/μl of nicotine-d3, phenol-d5, and pyridine-d5) was added and samples were further ground. Samples were then heated to 60°C for 30 minutes. Samples were centrifuged for 10 minutes at 14,000 rpm at 4°C. Supernatant containing the methanol phase (200 μl) was transferred to a microvial insert (0.25 ml conical glass with Ki, Western Analytical Products, Inc) and placed in a 2 ml GC vial (Agilent) and sealed with 11 mm silver crimp cap (Agilent) and stored at 4°C until GC/MS analysis.

GC/MS analysis was carried out using a GC/MS system consisting of a Hewlett- Packard (HP) 7683 auto-sampler, a HP 6890 gas chromatograph, and a HP 5973 mass selective detector. Chromatography was performed using a 30m x 0.25 μ DB-1701 column with a 0.25μm film thickness (J&W Scientific, Folsom, CA). The temperatures for injection, interface, and ion source were 200°C, 250°C, and 230°C, respectively. Helium flow was 1.2 ml/min. Mass spectra were recorded from 35 to 700 amu at 2.24 scans/sec. Tuning was done according to the instrument manual using Tris(perfluorobutyl)amine as the reference compound.

Aliquots of 20 μl of the samples were injected into a pre-column separation injector (ProSep 800, Apex Technologies, Inc.). The ProSep was set at an initial GC split mode followed by a splitless mode at 0.02 minutes, and then a GC split mode after 2.0 minutes. The temperature for the pre-column was held at 200°C for 1 minute, and then increased to 350°C at 200°C/min, and held for 112 minutes. The column oven temperature was held for 5 minutes at 50°C, then increased at 2.5°C/min to 299°C, and held for 10 minutes. The total run time was 114 minutes.

A compound list (quantitation database) was generated using HP enhanced data analysis software from the library search report. The putative identity of each compound was made by comparison with the spectrum from the Wiley library. The quality of the identification and quantity of the integration of registered compound was examined. The spectrum from each sample was calculated against this compound list to yield the compound list and their amount. Approximately 415 compounds were identified. The integration accuracy was edited manually. The registered compounds were normalized against the internal controls and then averaged from triplicate samples. The compounds were then analyzed by ranking and clustering. Ranking involved calculating the ratio between the amount of each compound detected in TRN-infected samples and the control samples and ordering the ratios in increasing and decreasing order. Clustering was done by grouping compounds from TRN-infected samples according to their trend to increase or decrease when compared to the controls and deriving a phylogenetic tree linking all the compounds.

EXAMPLE 13 Positive Sense Inhibition of EPSPS The 5-enolpyruvyl-shikimate-3 phosphate synthase (EPSPS) gene encodes an enzyme involved in the conversion of shikimic acid to chorismic acid and is the enzyme target of the herbicide Roundup^®. The EPSPS gene from N. tabacum was PCR amplified from the plasmid 736.1 using the following oligonucleotides: 5'- TGGTTCTGCAG TTATGCATGGCACAGATTAGCAGCATG-3' (upstream) (SEQ ID ΝO:57) and 5'- GGTACCAAGCTTGCGGCCGCTTAATGCTTGGAGTACTCCTG-3' (downstream) (SEQ JD NO:58). This PCR product was subcloned into pK20-2b-P/N-SmaI in the positive orientation to result in the construct pK20-2b-EPSPS(+). (Figure 19) When transcripts &om pK20-2b-EPSPS(+) were coinoculated with pLSB-1 transcripts onto N. benthamiana, chlorotic patches on the systemic leaves were observed after 10-14 days. Samples from infected plants were analyzed using GC/MS. GC/MS analysis revealed that there was a 47-fold increase in shikimic acid accumulation compared to the TRV-GFP control, as expected from a positive sense inhibition of the EPSPS enzyme and an accumulation of the enzyme substrate. Plants treated with Roundup showed a 69-fold increase in shikimic acid accumulation.

EXAMPLE 14 Identification of a NoplO-Like Small Nucleolar Ribonucleoprotein Gene Involved in The Regulation of Plant Growth by Cytoplasmic Inhibition of Gene Expression Using Viral Derived RNA.

One to two weeks after inoculation, transfected Nicotiana benthamiana plants were visually monitored for changes in growth rates, morphology, and color. One set of plants transfected with pK20-B12 (FIGURE 20) had an increase in stem circumference, distorted leaves and were severely stunted, DNA sequence analysis (FIGURE 21, SEQ ID NO: 17) revealed that this clone contained a Nicotiana benthamiana NoplO-like ribonucleoprotein open reading frame (ORF) in the positive orientation. The pK20-B12 encoded protein sequence exhibited a high degree of homology (62-68% and 76-78%, identities and positives, respectively) to yeast, insect and human Nop 10 small nucleolar ribonucleoproteins proteins (Table 5). The increase in stem circumference maybe a desired trait for the forest industry.

Table 5. pK20-B12 Amino acid Sequence Comparison

Score Expect Identities Positives

A. thaliana AC007109 103.5 bits (294) 3.9e-25 56/64 (87%) 59/64 (92%) Drosophila AE003828 78.9 bits (224) 1.0e-17 44/64 (68%) 50/64 (78%) Human AB043103 77.4 bits (220) 2.7e-17 40/60 (66%) 49/60 (81%) S. /7omσe AL157917 74.3 bits (211) 2.4e-16 40/64 (62%) 49/64 (76%) S. cerevisiae NP 058135.1 66.9 bits (190) 4.5e-14 36/58 (62%) 45/58 (77%) EXAMPLE 15

Identification of a DEAD Box RNA Helicase Gene Involved in The Regulation of Plant Growth by Cytoplasmic Inhibition of Gene Expression Using Viral Derived

RNA.

One to two weeks after inoculation, transfected Nicotiana benthamiana plants were visually monitored for changes in growth rates, morphology, and color. One set of plants transfected with pK20-Dl 1(1) (FIGURE 22) were stunted and had necrotic leaves. DNA sequence analysis (FIGURE 23, SEQ ID NO: 18) revealed that this clone contained a Nicotiana benthamiana DEAD box RNA helicase open reading frame (ORF) in the positive orientation. The pK20-Dl 1(1) encoded protein sequence exhibited a high degree of homology (70-74% and 82-85%, identities and positives, respectively) to yeast, insect and human DEAD box RNA helicase proteins (Table 6). The DEAD box RNA helicase family containing the highly conserved residues, Asp-Glu-Ala-Asp, are involved in diverse biological functions such as ribosome assembly, translation initiation, and RNA splicing. They modulate regulatory factors during organ maturation, cell growth and differentiation. Although the DEAD box RNA helicase family has been described in Arabidopsis thaliana (NAR review), the actual function of the genes encoding "putative computer-predicted helicases" has not been determined experimentally.

Table 6. pK20- Dll(l) Amino acid sequence comparison

Score Expect Identities Positives A. thaliana AL360314 293.2 bits (833) 4.5e-83 163/174 (93%) 170/174 (97%) S. pombe Z99162 241.1 bits (685) 2.1e-67 130/175 (74%) 149/175 (85%)

S. cerevisiae D89270 241.1 bits (685) 2.7e-67 130/175 (74%) 149/175 (85%) Drosophila Q27268 224.2 bits (637) 2.7e-62 123/175 (70%) 144/175 (82%) Human AK026614 221.8 bits (630) 1.4e-61 121/172 (70%) 144/172 (83%) EXAMPLE 16 Identification of a Putative Putrescine N-Methyltransferase Gene by Cytoplasmic Inhibition of Alkaloid Biosynthesis Using Viral Derived RNA.

One to two weeks after inoculation, transfected Nicotiana benthamiana plants were visually monitored for changes in growth rates, morphology, and color. One set of plants transfected with pK20-F12(l) (FIGURE 24) had an 8-fold decrease in the accumulation of the alkaloid nicotine (when compared with TRV-2b-GFP control (11.5 ng nicotine/mg tissue and 97.5 ng/mg tissue, respectively). DNA sequence analysis (FIGURE 25, SEQ ID NO: 19) revealed that this clone contained a Nicotiana benthamiana putrescine N- methylfransferase open reading frame (ORF) in the positive orientation. The pK20-F12(l) encoded protein sequence was compared to N tabacum putrescine N-methyltransferase AF126809 (96% and 96%, identities and positives, respectively).

EXAMPLE 17

Identification of a Methionine Synthase Gene Involved in The Regulation Of Plant Growth by Cytoplasmic Inhibition of Gene Expression Using Viral Derived RNA.

One to two weeks after inoculation, transfected Nicotiana benthamiana plants were visually momtored for changes in growth rates, morphology, and color. One set of plants transfected with pK20-B4(3) (FIGURE 26) were extremely stunted, had chlorotic and necrotic leaves, and had short spacing between the internodes. DNA sequence analysis (FIGURE 27, SEQ ID NO: 20) revealed that this clone contained a Nicotiana benthamiana methionine synthase open reading frame (ORF) in a positive orientation. The pK20-B4(3) encoded protein sequence exhibited a high degree of homology (87-96% and 93-97%, identities and positives, respectively) to potato, coffee, periwinkle, A. thaliana, and common ice plant methionine synthase/ —homocysteine S-methyltransferase proteins (Table 7).

Table 7. pK20-B4(3) Amino acid sequence comparison

Score Expect Identities Positives

S. tuberosum AF082893 258.4 bits (734) 7.8e-73 140/145 (96%) 142/145 (97%)

Coffea arabica AF220054 255.6 bits (726) 1.9e-71 138/145 (95%) 142/145 (97%) periwinkle Q42699 251.7 bits (715) 8.0e-71 136/145 (93%) 141/145 (97%) A. thaliana AB0U480 243.9 bits (693) 1.7e-68 131/145 (90%) 139/145 (95%) ice plant U84889 239.7 bits (681) 3.2e-67 126/144 (87%) 135/144 (93%)

EXAMPLE 18 Identification of a PRP19-like Spliceosomal Protein Gene Involved in the Regulation of Plant Growth by Cytoplasmic Inhibition of Gene Expression Using Viral Derived RNA.

One to two weeks after inoculation, transfected Nicotiana benthamiana plants were visually monitored for changes in growth rates, morphology, and color. One set of plants transfected with pK20-F12(4) (FIGURE 28) were extremely stunted. DNA sequence analysis (FIGURE 29, SEQ ID NO: 21) revealed that this clone contained a Nicotiana benthamiana PRP 19-like spliceosomal protein open reading frame (ORF) in the positive orientation. The pK20-F12(4) encoded protein sequence had homology (33-71% and 55- 86%, identities and positives, respectively) to A. thaliana, human nuclear matrix protein NMP200, rat and Drosophila proteins (Table 8).

Table 8. pK20-F12(4) Amino Acid Sequence Comparison

Score Expect Identities Positives

A. thaliana AC002332 180.9 bits (514) 8.8e-68 98/138 (71%) 119/138 (86%)

HumanNMP200 AJ131186 120.7 bits (343) 3.7e-31 83/216 (38%) 122/216 (56%) rat AB020022 120.7 bits (343) 3.7e-31 83/216 (38%) 122/216 (56%)

Drosophila AE003799 106.3 bits (302) 2.0e-26 73/216 (33%) 120/216 (55%)

EXAMPLE 19 Identification of a CRS2 Chloroplast Gene Involved in the Regulation Of Plant Color by Cytoplasmic Inhibition of Gene Expression Using Viral Derived RNA.

One to two weeks after inoculation, transfected Nicotiana benthamiana plants were visually monitored for changes in growth rates, morphology, and color. One set of plants transfected with pK20-G2(4) (FIGURE 30) developed white bleached leaves containing a slight yellow tinge. DNA sequence analysis (FIGURE 31, SEQ ID NO: 22) revealed that this clone contained a Nicotiana benthamiana CRS2-like protein open reading frame

(ORF) in the positive orientation. The CRS2 protein is involved in splicing the chloroplast group II nitrons. The pK20-G2(4) encoded protein sequence had homology (71-73% and 85-86%, identities and positives, respectively) to corn and A. thaliana CRS2 proteins (Table 9).

Table 9. pK20-G2(4) Amino Acid Sequence Comparison

Score Expect Identities Positives

Zea mays AF225708 293.9 bits (835) 4.6e-83 149/208 (71%) 180/208 (86%)

A. thaliana AL39U4S 288.7 bits (820) 1.9e-81 151/206 (73%) 178/206 (86%)

A. thaliana AB0U481 287.6 bits (817) 3.9e-81 147/202 (72%) 173/202 (85%)

EXAMPLE 20 Multigene Silencing Using Both TRV RNA-1 And RNA-2

When one gene is silenced using TRV RNA-1 and one or more genes are silenced using RNA-2, many parts of a biochemical pathway can be affected, allowing for more complex pathway manipulation than silencing only one gene. WhenN. benthamiana plants are coinoculated with the RΝA-1 construct pLSB-1 PDS(+) and the TRV RNA-2 construct pK20-2b-120(+)-RZ (from Example 7), a combination of phenotypes is expected: white leaf bleaching from PDS silencing and severe stunting and necrosis from 740AT #120 cDNA silencing. When N. benthamiana plants are coinoculated with the RΝA- 1 construct pLSB- 1 PDS(+) and the TRV RΝA-2 construct pK20-2b-EPSPS(+) (from Example 11), a combination of phenotypes is expected: white leaf bleaching from the PDS silencing along with chlorotic patches on the systemic leaves, and an increase in the accumulation of both phytoene and shikimic acid compared to the TRV-GFP control.

EXAMPLE 21

Multigene Expression By Further Modification Of TRV RNA-2

The native 2b subgenomic promoter (sgp) is used to drive the expression of one gene, while the heterologous PEBV sgp drives expression of another. GUS (beta- glucuronidase) is inserted into the 2b slot and GFP into the PEBV slot. When the resulting construct, pK20-GUS-GFP, is coinoculated with the RNA-1 construct pLSB-1 onto N. benthamiana plants, both GFP and GUS expression are expected simultaneously throughout the plant. EXAMPLE 22 Simultaneous Silencing By RNA-1 and Multigene Expression by RNA-2

When N benthamiana plants are coinoculated with the RNA-1 construct pLSB-1 PDS (+) and the RNA-2 construct pK20-Gus-GFP, both GFP and Gus expression and PDS silencing are expected simultaneously throughout the plant.

EXAMPLE 23 Multigene Expression by Further Modification of TRV RNA-2

The 2b sgp is used to drive the expression of one gene, the PEBV sgp is used to drive the expression of a second, and the original 2c sgp is used to drive the expression of a third gene. GUS is inserted into the 2b slot, GFP into the PEBV slot, and luciferase into the 2c slot. When the resulting construct, pK20-GUS-GFP -luciferase, is coinoculated with the RNA-1 construct pLSB-1 onto N. benthamiana plants, simultaneous expression of GFP, GUS, and luciferase is expected throughout the plant.

EXAMPLE 24

Simultaneous Silencing by RΝA-1 and Multigene Expression by RNA-2

After N. benthamiana plants are coinoculated with the RΝA-1 construct pLSB-1 PDS (+) and the RNA-2 construct pK20-GUS-GFP-luciferase, simultaneous expressing of GFP, GUS and luciferase and silencing of PDS are expected throughout the plant. Although the invention has been described with reference to the presently preferred embodiments, it should be understood that various modifications can be made without departing from the spirit of the invention.

Deposit of Biological Materials The following biological materials have been deposited with the American Type

Culture Collection (ATCC) at 10801 University Blvd., Manassas, VA 20110-2209, in compliance with the requirements of the Budapest Treaty On The International Recognition Of The Deposit Of Microorganisms For The Purpose Of Patent Procedure, on the dates and were assigned the ATCC accession numbers indicated below. Deposited Material Deposit Date Accession No.

Barley Stripe Mosaic Virus cDNA: DH5α: γ.Δ γt.GFP Jan. 19, 2001 PTA-2930

Barley Stripe Mosaic Virus cDNA: DH5α: /3.GFP: :2A Jan. 19, 2001 PTA-2931

Barley Stripe Mosaic Virus cDNA: DH5α: γ.GFP: :HA: :2A Jan. 19, 2001 PTA-2932

Barley Stripe Mosaic Virus cDNA: DH5α: γ.ϊ>PDS4-as Jan. 19, 2001 PTA-2933

Barley Stripe Mosaic Virus cDNA: DH5α: j8.42.Spl Jan. 19, 2001 PTA-2934

Barley Stripe Mosaic Virus cDNA: DH5α: β.Δβt.GFP Jan. 19, 2001 PTA-2935

Barley Stripe Mosaic Virus cDNA: DH5α: γ.2A::GFP::H Jan. 19, 2001 PTA-2936

Barley Stripe Mosaic Virus cDNA: DH5α: γ/bPDS4 Jan. 19, 2001 PTA-2937

Barley Stripe Mosaic Virus cDNA: DH5α: α.42 Jan. 19, 2001 PTA-2938

Barley Stripe Mosaic Virus cDNA: DH5α: γ.42 Jan. 19, 2001 PTA-2939

Barley Stripe Mosaic Virus cDNA: DH5α: /3.GFP: : βτ> Jan. 19, 2001 PTA-2940

Barley Stripe Mosaic Virus cDNA: DH5α: γ.Δγa Jan. 19, 2001 PTA-2941

Barley Stripe Mosaic Virus cDNA: DH5α: β.Δβa Jan. 19, 2001 PTA-2942

Barley Stripe Mosaic Virus cDNA: DH5α: γ.Δγa. Δγt.GFP Jan. 19, 2001 PTA-2943

Barley Stripe Mosaic Virus cDNA: DH5α: DH5α?: γ.GFP:: jb Jan. 25, 2001 PTA-2944

The present invention is not to be limited in scope by the biological material deposited since the deposited embodiments are intended as illustrations of the individual aspects of the invention, and any biological material, or constructs which are functionally equivalent are within the scope of this invention. Indeed, various modifications of the invention in addition to those shown and described herein will become apparent to those skilled in the art from the foregoing description and accompanying drawings. Such modifications are intended to fall within the scope of the appended claims.

Claims (34)

WHAT IS CLAIMED IS:

1. A monopartite viral vector, comprising:

modified tobravirus RNA-1 comprising an inserted foreign RNA sequence operably linked to the 3 '-end of the stop codon of the RNA sequence that codes for a 16k Da cysteine-rich protein of RNA- 1.

2. A bipartite RNA viral vector, comprising: (a) modified tobravirus RNA-1 comprising an inserted foreign RNA sequence, operably linked to the 3 'end of the stop codon of the RNA sequence that codes for a 16k Da cysteine-rich protein of RNA-1; and (b) tobravirus RNA-2

3. A bipartite RNA viral vector, comprising:

(a) modified tobravirus RNA-1 comprising a first foreign RNA sequence, operably linked to 3 '-end of the stop codon of the RNA sequence that codes for a 16k Da cysteine-rich protein of RNA- 1; (b) modified tobravirus RNA-2 comprising a promoter-gene construct, which comprises a subgenomic promoter operably linked to the 5' end of a second foreign RNA sequence, wherein said promoter-gene construct is inserted in place of the 2C gene.

4. A bipartite RNA viral vector, comprising:

(a) tobravirus RNA- 1 ;

(b) modified tobravirus RNA-2; wherein said modified tobravirus RNA-2 comprises one or more promoter-gene constructs comprising a subgenomic promoter and a foreign RNA sequence, wherein said subgenomic promoter is operably linked to the 5 ' end of said foreign RNA sequence, and said promoter-gene construct is inserted in place of the 2c gene and without removal of the 2b gene of a tobravirus.

5. A bipartite RNA viral vector, according to Claim 4, wherein said modified tobravirus RNA-2 further comprises Not I, Pst I, and Xho sites.

6. The viral RNA vector according to any one of Claims 1-4, wherein the foreign RNA is either a complete open reading frame or a partial open reading frame.

7. The viral RNA vector according to any one of Claims 1-4, wherein the foreign RNA is in either a positive sense or an antisense orientation.

8. The RNA viral vector according to Claim 6, wherein said foreign RNA codes for part of a protein.

9. The RNA viral vector according to Claim 8, wherein said vector is a silencing vector.

10. The RNA viral vector according to Claim 6, wherein said foreign RNA codes for a protein.

11. The RNA viral vector according to Claim 10, wherein said vector is a silencing vector or an expression vector.

12. The RNA viral vector according to any one of Claims 1-4, wherein the foreign

RNA sequence is obtained from any member of a library of RNA sequences taken from a eukaryotic or prokaryotic species.

13. The viral RNA vector according to Claim 6, wherein said foreign RNA encodes for all or part of a Nop 10-like small nucleolar ribonucleoprotein.

14. The viral RNA vector according to Claim 6, wherein said foreign RNA encodes for all or part of aDEAD box RNA helicase.

15. The viral RNA vector according to Claim 6, wherein said foreign RNA encodes for all or part of putrescine N-methyltransferase.

16. The viral RNA vector according to Claim 6, wherein said foreign RNA encodes for all or part of methionine synthase.

17. The viral RNA vector according to Claim 6, wherein said foreign RNA encodes for all or part of a PRP 19-like spliceosomal protein.

18. The viral RNA vector according to Claim 6, wherein said foreign RNA encodes for all or part of a CRS2 protein.

19. The viral RNA vector according to Claim 6, wherein said foreign RNA encodes for all or part of a GTP-binding protein.

20. A method of expressing one or more foreign gene in a plant host, comprising: infecting a plant host with the RNA viral vector of any one of Claims 1-4, whereby the foreign gene is expressed in the plant host.

21. The method according to Claim 20, furthering comprising allowing the viral vector to infect the plant systemically.

22. A method of silencing one or more plant host genes, comprising: infecting a plant host with the RNA viral vector of Claims 1-4, whereby the expression of said foreign RNA sequence causes silencing of an endogenous plant host gene.

23. The method according to Claim 22, furthering comprising allowing the viral vector to infect the plant systemically.

24. A method of simultaneously silencing a plant host gene and expressing a foreign gene, comprising: infecting a host with the bipartite RNA viral vector of Claim 3, whereby the first foreign RNA sequence causes silencing of an endogenous gene of a plant host, and the second foreign RNA is expressed in the plant host.

25. A method of simultaneously silencing a plant host gene and expressing a foreign gene, comprising: infecting a host with the bipartite RNA viral vector of Claim 3; whereby the second foreign RNA sequence causes silencing of an endogenous gene of a plant host, and the first foreign RNA is expressed in the plant host.

26. A method of silencing one or more host genes, comprising: infecting a host with the bipartite RNA viral vector of Claim 1; whereby both the first and the second foreign RNA sequence cause silencing of a host gene.

27. The method according to Claims 24, 25 or 26, furthering comprising allowing the viral vector to infect the plant systemically.

28. A method of silencing an endogenous gene in a plant host comprising the steps of: infecting a plant host with a bipartite RNA viral vector that comprises: (a) tobravirus RNA- 1 ; (a) modified tobravirus RNA-2 that comprises a promoter-gene construct comprising a subgenomic promoter and a foreign RNA sequence that codes for all or part of a protein, wherein said subgenomic promoter is operably linked to the 5' end of said foreign RNA sequence, and said promoter-gene construct is inserted in place of the 2C gene of a tobravirus.

29. A method of altering an alkaloid content in a plant host comprising the steps of: infecting a plant host with a bipartite RNA viral vector that comprises:

(a) tobravirus RNA- 1 ;

(b) modified tobravirus RNA-2 that comprises a promoter-gene construct comprising a subgenomic promoter and a foreign RNA sequence involved in the biosynthesis of alkaloids, wherein said subgenomic promoter is operably linked to the 5' end of said foreign RNA sequence, and said promoter-gene construct is inserted in place of the 2C gene of a tobravirus.

30. A method of altering an alkaloid content in a plant host comprising the steps of: infecting a plant host with a RNA viral vector that comprises modified tobravirus

RNA-1 comprising a foreign RNA sequence involved in the biosynthesis of alkaloids operably linked to the stop codon of the RNA sequence which codes for a 16k Da cysteine-rich protein of RNA- 1.

31. A method according to Claims 29 or 30, wherein said foreign RNA gene encodes for all or part of putrescine N-methyltransferase.

32. A plant host infected by a viral RNA vector according to any one of Claims 1 -4.

33. A plant host having an altered alkaloid content, wherein said plant host is prepared according to Claims 29 or 30.

34. A method of compiling a plant functional gene profile, comprising:

(a) preparing a library of DNA or RNA sequences from a donor plant, and constructing recombinant viral nucleic acids comprising an unidentified nucleic acid insert obtained from said library in either a positive sense or an antisense orientation, wherein said recombinant viral nucleic acids are obtained from a tobravirus;

(b) infecting a plant host with one or more said recombinant viral nucleic acids;

(c) transiently expressing said unidentified nucleic acid in the plant host;

(d) determining one or more phenotypic or biochemical changes in the plant host; (e) identifying an associated trait relating to a phenotypic or biochemical change; (f) identifying said recombinant viral nucleic acid that results in said one or more changes in the plant host; (g) repeating steps (b) - (f) until at least one nucleic acid sequence associated with said trait is identified, whereby a functional gene profile of the plant host or of the plant donor is compiled. od of compiling a plant functional gene profile, comprising: (a) preparing a library of DNA or RNA sequences from a donor plant, and constructing recombinant viral nucleic acids comprising an unidentified nucleic acid insert obtained from said library, wherein recombinant viral nucleic acids are obtained from a tobravirus;

(b) infecting a plant host with one or more said recombinant viral nucleic acids;

(c) transiently expressing said recombinant nucleic acid in the plant host;

(d) determrning one or more changes in a phenotypic or biochemical trait in the plant host; (e) identifying said recombinant viral nucleic acid that results in one or more changes in the plant host;

(f) determining the sequence of said unidentified nucleic acid insert; and

(g) repeating steps (b)-(f) until at least one nucleic acid sequence associated with said trait is identified, whereby a functional gene profile of the plant host or the plant donor is compiled. od of changing the phenotype or biochemistry of a plant host, comprising:

(a) infecting a plant host with the RNA viral vector any one of Claims 1-4,

(b) expressing transiently said foreign RNA sequence in said plant host; and

(c) changing one or more phenotypic or biochemical characteristics in said plant host; and od of determining the presence of a trait in a plant host, comprising:

(a) preparing a library of DNA and RNA sequences of a plant donor; (b) constructing recombinant viral nucleic acids comprising an unidentified nucleic acid insert obtained from said library in an antisense or a positive sense orientation, wherein said recombinant viral nucleic acid are obtained from a tobravirus; (c) infecting said plant host with one or more said recombinant viral nucleic acids, and expressing transiently said unidentified nucleic acid in said plant host such that one or more phenotypic or biochemical changes occurs;

(d) determining one or more biochemical or phenotypic traits relating to said changes in said plant host; and

(e) comparing said one or more biochemical or phenotypic traits to a plant host that is uninfected.